Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage Girls (Englisch)
- Neue Suche nach: Westra, T. A.
- Neue Suche nach: Postma, M. J.
- Neue Suche nach: Westra, T. A.
- Neue Suche nach: Postma, M. J.
In:
VALUE IN HEALTH
;
17
, 7
;
A676-A677
;
2014
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage Girls
-
Beteiligte:Westra, T. A. ( Autor:in ) / Postma, M. J. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 17, 7 ; A676-A677
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2014
-
Format / Umfang:A676-A677
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 17, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A323
-
The Cost of Costing Treatments Incorrectly: Errors in the Application of Drug Prices in Economic Models Due to Differing Patient WeightsHatswell, A. J. / Porter, J. / Hertel, N. / Lee, D. et al. | 2014
- A324
-
The Value of Risk-Stratified Information in the National Lung Cancer Screening TrialSoeteman, D. I. / Cohen, J. T. / Neumann, P. J. / Wong, J. B. / Kent, D. M. et al. | 2014
- A325
-
Preferences for Prioritizing Patients with Rare Diseases: a Survey of the General Population in SwedenWiss, J. / Levin, L. et al. | 2014
- A326
-
Economic orphans? the prevalence of child-specific utilities in nice appraisals for paediatric indicationsMontgomery, S. / Hassan, M. / Kusel, J. et al. | 2014
- A327
-
Work Productivity Loss and Indirect Costs Associated with New Cardiovascular Events in High-Risk Patients with Hyperlipidemia - Estimates from Population-Based Register Data in SwedenBanefelt, J. / Hallberg, S. / Fox, K. M. / Mesterton, J. / Paoli, C. J. / Johansson, G. / Levin, L. / Sobocki, P. / Gandra, S. R. et al. | 2014
- A328
-
Impact of Morbidity in Populations of North London Clinical Commissioning Groups on Patient Admission Rates and Gp ReferralsGroom, Z. C. / Burgon, J. / Eddowes, L. A. / Wilson, T. / Kusel, J. et al. | 2014
- A329
-
Exploring the Flaws in Clinical Data that Lead to Rejection of Nice SubmissionsHendrich, J. / Griffiths, E. A. et al. | 2014
- A330
-
Mapping from SF-6D to EQ-5D: Changes in Estimates Based on the Choice of AlgorithmHatswell, A. J. / Ito, T. / Ganguly, R. / Nassens, D. / Almond, C. et al. | 2014
- A331
-
Differences Between Hypothetical and Experience-Based Value Sets for Eq-5d: Implications for Decision MakersAronsson, M. / Husberg, M. / Kalkan, A. / Eckard, N. / Alwin, J. et al. | 2014
- A332
-
Comparative Efficacy and Safety of Empagliflozin with Other Anti-Diabetic Drugs for the Treatment of Patients with Type 2 Diabetes Mellitus Who are Failing InsulinThorlund, K. / Siliman, G. / Eapen, S. / Lund, S. / Palencia, R. et al. | 2014
- A333
-
Glycemic, Lipid, and Blood Pressure Control Among Individuals with Type 2 Diabetes Mellitus in Saudi ArabiaOsenenko, K. M. / Szabo, S. M. / Donato, B. M. / Korol, E. E. / Qatami, L. / Al Jaser, S. / Al Saggabi, A. / El Seid, M. E. / Maclean, R. / Levy, A. R. et al. | 2014
- A334
-
Treatment Maintenance Duration of Dual Therapy with Metformin and Sitagliptin in Type 2 Diabetes – Real-World Data From Odyssee StudyLeproust, S. / Dallongeville, J. / Valensi, P. / Boutmy, E. / Moisan, C. / chanut-Vogel, C. / de Pouvourville, G. et al. | 2014
- A335
-
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors: Systematic Review and Meta-AnalysisPérez, A. / Franch, J. / Fuster, E. / Paz, S. / Prades, M. / Granell, M. et al. | 2014
- A336
-
Progression of Physiological Parameters Over Time in Type 1 Diabetes Mellitus Patients in FranceBeaudet, A. / Ong, R. C. et al. | 2014
- A337
-
Cost-Effectiveness Analysis of Autocoded and Manually Coded Blood Glucose Meters In Diabetes TreatmentYagudina, R. / Kulikov, A. / Babiy, V. et al. | 2014
- A338
-
Benefit Of Positive Airway Pressure (Pap) Therapy In Sleep Apnoea (Sa) Patients With Type Ii Diabetes Mellitus (T2dm) In Germany: A Retrospective Comparative Cohort Analysis Based On A Statutory Health Insurance DatabaseDoess, A. / Zucca, F. / Woehrle, H. / Brueggenjuergen, B. et al. | 2014
- A339
-
Metformin in Combination With Dipeptidyl Peptidase-4 Inhibitors or Sulfonylureas in The Treatment of Type 2 Diabetes: Clinical And Economic ImpactSicras-Mainar, A. / Navarro-Artieda, R. et al. | 2014
- A340
-
Key Cost Drivers Of Type 2 Diabetes Mellitus: an International Literature ReviewVilloro, R. / Zozaya, N. / Hidalgo, A. / Oliva, J. / Rubio, M. et al. | 2014
- A341
-
Multimorbidity Pharmaceutical Cost of Diabetes MellitusVivas-Consuelo, D. / Alvis-Estrada, L. / Uso-Talamantes, R. / Caballer-Tarazona, V. / Buigues-Pastor, L. / Sancho-Mestre, C. et al. | 2014
- A342
-
Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in Czech RepublicTroelsgaard, A. / Pitcher, A. / Veselá, . / Lovato, E. / Hemels, M. et al. | 2014
- A343
-
Health Economic Evaluation of Canagliflozin in the Treatment of Type 2 Diabetes Mellitus in PortugalTroelsgaard, A. / Knudsen, M. / Maia-Lopes, S. / Luz, M. / Hemels, M. et al. | 2014
- A344
-
Economic Assessment of Delaying Insulin Treatment Through The Use of Newer Anti-Diabetic Agents, Dapagliflozin (Forxiga®) And Exenatide (Bydureon®), Both As Add-On To Metformin; A Cost-Effectiveness Analysis From A Uk Nhs PerspectiveCharokopou, M. / Vioix, H. / Verheggen, B. G. / Maddocks, D. / Bratt, T. / Franks, D. et al. | 2014
- A345
-
Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In SlovakiaRoze, S. / Lynch, P. / Machova, R. / Micieta, V. / Dunne, N. / Klots, M. / Karamalis, M. / Martinka, E. et al. | 2014
- A346
-
The Cost-Effectiveness of Canagliflozin Compared With Liraglutide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin and Sulfonylurea In FranceTroelsgaard, A. / Pitcher, A. / Granados, D. / Hemels, M. / Lloyd, A. et al. | 2014
- A347
-
The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness StudiesBaptista, A. / Teixeira, I. / Romano, S. / Vaz, C. A. / Perelman, J. et al. | 2014
- A348
-
Economic Evaluation of Lanreotide Autogel in the Management of Acromegaly in GreeceKousoulakou, H. / Panayiotou-Pazaitou, K. / Pantazi, E. / Tsentidis, C. / Tzanela, M. / Vryonidou, A. / Markussis, V. / Eleftheriou, C. / Geitona, M. et al. | 2014
- A349
-
Comparative Cost-Effectiveness Analysis of Adding Twice-Daily Exenatide To Insulin Glargine Versus Adding Insulin Lispro To Treat Type 2 Diabetes In SpainSánchez-Covisa, J. / Capel, M. / Baeten, S. / Verheggen, B. G. et al. | 2014
- A350
-
Cost-Effectiveness of Empagliflozin (Jardiance®) 10 Mg And 25 Mg Administered As An Add-on To Metformin Compared To Other Sodium-Glucose Co-Transporter 2 Inhibitors (Sglt2is) for Patients With Type 2 Diabetes Mellitus (T2dm) In The UKAguiar-Ibáñez, R. / Palencia, R. / Kandaswamy, P. / Li, L. et al. | 2014
- A351
-
Examining The Role Of Insulin Pen Devices In Acute Care Settings: A Review And Analysis of Health Resource UtilizationSmallwood, C. A. / Lamarche, D. / Chevrier, A. et al. | 2014
- A352
-
Cost Analysis of Severe Hypoglycemia in Treated Type 2 Diabetic Patients According to Anti-Hyperglycemic Agent TherapyLaires, P. / Conceição, J. / Dores, J. / Araújo, F. / Silva, C. / Radican, L. / Nogueira, A. M. et al. | 2014
- A353
-
The Relationship Between Macular Edema and Health Outcomes Among Patients With Diabetes in Western EuropePignot, M. / DiBonaventura, M. et al. | 2014
- A354
-
Self-Reported Frequency and Impact of Non-Severe Hypoglycaemia in Insulin-Treated Adults in the UKChubb, B. / Jensen, M. M. / Frier, B. M. et al. | 2014
- A355
-
Assessment of Effect of Continuous Subcutaneous Insulin Infusion Treatment, Insulin Analog And Human Insulin of Children With DiabetesPetkova, E. / Petkova, V. / Petrova, G. / Dimitrova, M. / Konstantinova, M. et al. | 2014
- A356
-
Racial Disparities in Type 2 Diabetes Health Care Utilization in Medicaid Adults With Developmental DisabilitiesPatel, I. / Erickson, S. / Bagozzi, R. P. / Chang, J. / Caldwell, C. / Woolford, S. / Balkrishnan, R. et al. | 2014
- A357
-
Effect of A Pharmacy-Based Diabetes Management Program on Glycemic Control in an Inpatient General Medicine PopulationEfird, L. / Shermock, K. M. et al. | 2014
- A358
-
A Comparative Analysis on The Reimbursement Status Of Sensor Augmented Pump Therapy in Turkey and Other Selected CountriesSeyhun, O. / Erdol, S. / Can, H. / Erdogan, E. et al. | 2014
- A359
-
Exploring The Determinants of Endocrinologist Visits In FranceAndrade, L. F. / Rapp, T. / Sevilla-Dedieu, C. et al. | 2014
- A360
-
Cost of Severe Hypoglycaemia in Hospitalized Patients In Poland- Is It Financed and Reported in a Right Way?Czech, M. / Jaron, N. / Pietrzyk, A. / Franek, E. et al. | 2014
- A361
-
Efficacy of The Automated Target Glucose Control: A Systematic ReviewYoo, K. J. et al. | 2014
- A362
-
The Comparison Of Clinical Impact Between Entecavir And Tenofovir In Chronic Hbv InfectionShen, W. C. et al. | 2014
- A363
-
Budget Impact Analysis Of Sofosbuvir For The Treatment Of Hepatitis C In The Veneto Region, ItalyAdami, S. / Aiello, A. / Magrì, M. R. / Nocera, S. / Piovesan, S. / Alberti, A. / Scroccaro, G. et al. | 2014
- A364
-
Direct Health Care Costs Associated With Opioid-Induced ConstipationLawson, R. / Haycock, L. / Laxman, K. / King, F. / Gardner, K. et al. | 2014
- A365
-
Economic Evaluation Of Various Strategies For Antiviral Therapy For Previously Treated Patients With Chronic Hcv Genotipe 1 InfectionAvxentyeva, M. / Pyadushkina, E. / Derkach, E. V. et al. | 2014
- A366
-
Cost-Effectiveness Analysis Of Antiviral Pharmacotherapies For Treatment Of Chronic Hepatitis C Virus Infection In RussiaPyadushkina, E. / Avxentyeva, M. / Omelyanovsky, V. V. / Treur, M. / Westerhout, K. Y. et al. | 2014
- A367
-
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver TransplantationCortesi, P. A. / Mantovani, L. / Ciaccio, A. / Rota, M. / Cesana, G. / Strazzabosco, M. / Belli, L. S. et al. | 2014
- A368
-
Quality Of Life Of Diarrheal Children And Caregivers In ThailandRochanathimoke, O. / Postma, M. / Thavorncharoensap, M. / Riewpaiboon, A. / Thinyounyong, W. et al. | 2014
- A369
-
Self-Reported Health Related Quality Of Life Of Hepatitis C Virus (Hcv) Genotype 1 Patients With And Without Comorbid ConditionsNwankwo, C. / Sung, A. H. / Pike, J. et al. | 2014
- A370
-
Real World Studies Using Japanese Administrative Databases: Chronic Hepatitis C Treatment Pattern And Resource UseCrawford, B. / Tang, A. / Li, H. / Burns, L. / Wada, K. / McDonald, J. et al. | 2014
- A371
-
Comparison Of The Burden Of Ibs With Constipation On Health-Related Quality Of Life (Hrqol), Work Productivity, And Health Care Utilization To Asthma, Migraine, And Rheumatoid Arthritis In The Us, Uk, And FranceTaylor, D. C. / Kosinski, M. / Reilly, K. / Lindner, L. et al. | 2014
- A372
-
Work Productivity Improvement Associated With Apremilast, An Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis Results Of A Phase 3, Randomized, Controlled TrialZhang, F. / Tencer, T. / Li, S. / Strand, V. et al. | 2014
- A373
-
Comparative Effectiveness of Biological Agents With Diseases Modifying Anti-Rheumatic Drugs For Methotrexate Failure Rheumatoid Arthritis Patients: A Baysian Mixed Treatment ComparisonChoi, M. / Hyun, M. K. / Choi, S. / Tchoe, H. J. / Lee, S. Y. / Son, K. M. / Jung, Y. O. / Kim, H. A. et al. | 2014
- A374
-
Heal Rate In 4,190 Fresh Fractures Treated With Low-Intensity Pulsed Ultrasound (Lipus)Zura, R. / Mehta, S. / Della, R. G. / Jones, J. / Steen, R. G. et al. | 2014
- A375
-
Mast (Minimal Access Spinal Technologies) Versus Open Surgery: Cost Analysis From Hospital PerspectiveLukyanov, V. / Melik-Gusseinov, D. / Borgman, B. / Demourenko, D. / Mlyavykh, S. et al. | 2014
- A376
-
Burden Of Disease Analysis Of Ankylosing Spondylitis In HungaryHegyi, R. / Nagy, B. / Koncz, A. / Huybrechts, I. / Lavicky, J. / Ferenczik, A. et al. | 2014
- A377
-
The Pension Costs of Musculoskeletal Diseases. Estimation of the Economic Burden Borne by the Italian Social Security SystemRusso, S. / Mariani, T. T. / Migliorini, R. / Marcellusi, A. / Mennini, F. S. et al. | 2014
- A378
-
Treating to the Target of Das28 < 2.6 in Rheumatoid Arthritis: the Impact of Efficacy on Cost EffectivenessAlemao, E. / Johal, S. / Al, M. J. / Rutten-van, M. l. et al. | 2014
- A379
-
Cost-Effectiveness of Celecoxib and Non Selective Non Steroidal Anti-Inflammatory Drug (Nsaid) Therapy for the Treatment of Osteoarthritis in Spain: A Decision-Tree ModelDe, L. J. / Rejas, G. r. / Oteo, l. et al. | 2014
- A380
-
Cost-Effectiveness Analysis of Etanercept in the Treatment of Rheumatoid Arthritis In PortugalMateus, C. / Moura, A. et al. | 2014
- A381
-
Rehabilitation In Resurfacing Hip Arthroplasty Patients: Preliminary Cost-Effectiveness Results From A Clinical TrialFusco, F. / Campbell, H. / Newman, M. / Barker, K. et al. | 2014
- A382
-
Work Productivity Loss Due To Rheumatoid Arthtiris (Ra), Crohn's Disease (Cd) And Psoriasis (Ps) In PolandWladysiuk, M. / Bebrysz, M. / Fedyna, M. / Haldas, M. / Rutkowski, J. et al. | 2014
- A383
-
Systematic Review and Meta-Analysis of Persistence With Denosumab in Patients With OsteoporosisJonsson, E. / Cheng, L. I. / Ström, O. / Intorcia, M. / Karlsson, L. et al. | 2014
- A384
-
Treatment Persistence With Subcutaneous Biologic Therapies in Patients With Psoriatic Arthritis (Psa)Lyu, R. / Ding, Q. / Govoni, M. / Fan, T. et al. | 2014
- A385
-
Long-Term Maintenance of Improvements in Patient-Reported Outcomes With Certolizumab Pegol in Patients With Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 96-Week Results of the Rapid-Axspa StudySieper, J. / Kivitz, A. / van Tubergen, A. / Deodhar, A. / Szegvari, B. / Nurminen, T. / Landewé, R. et al. | 2014
- A386
-
Functional Status, Quality of Life And Work Disability for Patients With Rheumatic Diseases in GreeceAthanasiadi, E. / Fragoulakis, V. / Vozikis, A. et al. | 2014
- A387
-
Sustained Improvements in Workplace and Household Productivity and Social Participation With Certolizumab Pegol Over 96 Weeks in Patients With Psoriatic ArthritisKavanaugh, A. / Gladman, D. / van, d. H. / Purcaru, O. / Mease, P. J. et al. | 2014
- A388
-
Predicting the Burden of Knee Arthroplasty Revision Over A 20-Year HorizonComas, M. / Guerrero-Ludueña, R. E. / Espallargues, M. / Coll, M. / Pons, M. / Sabatés, S. / Allepuz, A. / Castells, X. et al. | 2014
- A389
-
The Use of Clinical Data Repository for the Establishment of an Osteoporosis Registry in A Large Health Organization in Israel: Epidemiologic and Pharmaepidemiologic FindingsGoldshtein, I. / Shalev, V. / Chodick, G. / Chandler, J. / Martin, N. A. / ish, S. S. et al. | 2014
- A390
-
The Burden of Parkinson Disease Amongst Caregivers in Spain Over 4 YearsMartinez, P. / Rodriguez-Blazquez, C. / Paz, S. / Lizán, L. / Forjaz, M. J. / Frades, B. / Jimenez, O. L. et al. | 2014
- A391
-
Image-Guided Navigation Systems (IGNS) Improve Accuracy of Catheter Placement in Shunted Hydrocephalus PatientsAnnoni, E. / Joedicke, H. / Birinyi-Strachan, L. et al. | 2014
- A392
-
The Characteristics of Multiple Sclerosis in IranKhanizadeh, H. / Nikkhah, K. / Izham, M. et al. | 2014
- A393
-
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital PerspectiveViriato, D. / Carrasco, J. / Fonseca, J. / Pacheco, R. et al. | 2014
- A394
-
Costs Associated with the Use of Enzyme-Inducing Anti-Epileptic Drugs Versus Non-Enzyme-Inducing Anti-Epileptic Drugs: A Systematic ReviewXiong, T. / Gallagher, E. / MacGilchrist, K. S. / Thieffry, S. et al. | 2014
- A395
-
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in IranKhanizadeh, H. / Izham, M. / Nikkhah, K. et al. | 2014
- A396
-
Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia: Results from the National Cross-Sectional StudyOndrusova, M. / Psenkova, M. / Donath, V. et al. | 2014
- A397
-
Economic Evaluation of Lacosamide in the Management of Epileptic Partial Onset Seizures in GreeceGeitona, M. / Kousoulakou, H. / Carayianni, V. / Baltogiannis, C. / Garganis, K. / Gatzonis, S. / Giannakodimos, S. / Kodounis, A. / Nasios, G. / Polychronopoulos, P. et al. | 2014
- A398
-
The Long-Term Value of Glatiramer Acetate for the Treatment of Relapsing Remitting Multiple Sclerosis in the NetherlandsPurchase, J. L. / Wilson, L. E. / Prüfert, A. et al. | 2014
- A399
-
Cost-Effectiveness Model Results of Intrathecal Baclofen Therapy Compared to Conventional Medical Management in Patients with Non-Focal Disabling Spasticity Who are Resistant or Intolerant to Oral Therapy at the Institut GuttmannSlof, J. / Serrano, D. / Álvarez, M. / Álvarez López-Dóriga, M. / Marqués, T. / Benito, J. / Vidal, J. et al. | 2014
- A400
-
Persistence with Fingolimod Versus Dimethyl Fumarate in Patients with Multiple Sclerosis: Retrospective Analysis of us Open-Source Pharmacy DataBergvall, N. / Lahoz, R. / Nazareth, T. / Korn, J. R. et al. | 2014
- A401
-
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking ImpairmentLiu, Y. / McNeill, M. / Lee, A. / Zhong, J. / Mehta, L. R. et al. | 2014
- A402
-
The Humanistic and Economic Burden of Partial Onset Seizures in the Europe Five and Brazil Using a Patient SurveyGupta, S. / Forsythe, A. / Pomerantz, D. / Tsong, W. et al. | 2014
- A403
-
Antiepileptic Drug (AED) Treatment Sequencing in the Uk in Patients with Epilepsy: Real-Life Practice Data Using CPRDBorghs, S. / Logan, J. / Hong, L. S. / Butt, T. et al. | 2014
- A404
-
Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking Injectable and Oral Disease Modifying Treatments in the United StatesNarayanan, S. / O'Meara, P. / White, J. / Chan, J. / Gabriele, S. et al. | 2014
- A405
-
The Effect of Degressive Financing Method on the Hungarian Drg Based Hospital Reimbursement Between 2011-2013Endrei, D. / Zemplényi, A. / Ágoston, I. / Molics, B. / Csákvári, T. / Danku, N. / Vajda, R. / Boncz, I. et al. | 2014
- A406
-
Price Comparison in the European Pharmaceutical MarketKögel, S. / Walter, E. et al. | 2014
- A407
-
Economic Burden of Intravenous Iron Products In Public Hospitals of Paris and Impact of Their New Hospital-Restricted StatusTherasse, C. / Bocquet, F. / Fusier, I. / Cordonnier, A. L. / Sinègre, M. et al. | 2014
- A408
-
Boosting Biosimilars Uptake in European CountriesYoung, K. E. / Rémuzat, C. / Urbinati, D. / Toumi, M. et al. | 2014
- A409
-
A Multi-Stakeholder (Physician, Payer, Patient, and Industry) Qualitative Analysis of the Policies That Would Support A Sustainable European Biosimilars Medicines Market Combined With A Quantitative Analysis of the Multi-Stakeholder Benefits A Sustainable Medicines Market Would DeliverWhitehouse, J. T. / Teale, C. W. / Glover, J. C. / Taylor, C. / Lino, M. V. et al. | 2014
- A410
-
Impact of Health Policy Changes on the Growth Locally Manufactured and Imported Pharmaceutical Markets of Top Selling Atc1 Phramaceutical Group (Alimentary and Metabolism (A0) In TurkeyKockaya, G. / Yenilmez, F. B. / Saylan, M. / Safak, Y. E. / Tatar, M. / Hilal, V. E. / Vural, I. M. / Akbulat, A. / Gursoz, H. / Artiran, G. et al. | 2014
- A411
-
Generic Penetration Within Top-10 Genericized Molecules – Greece Versus Major European CountriesCharitonidis, S. / Kofinas, K. / Katsoulakis, M. / Papadopoulos, K. / Ollandezos, M. / Kyriopoulos, J. et al. | 2014
- A412
-
An Analysis of the 2014 Moroccan Drug Price CutsHollis, M. / Ando, G. / Izmirlieva, M. et al. | 2014
- A413
-
Pricing of Medicines In Poland – Two-Year Overview Of How The New Law Affected Costs Of ReimbursementSzmurlo, D. / Wladysiuk, M. / Plisko, R. et al. | 2014
- A414
-
Accessing the Medical Device Market in the People's Republic of China--Policy Changes Since the Restructuring of the China FdaZhang, S. X. / Kriza, C. / Kolominsky-Rabas, P. L. et al. | 2014
- A415
-
Non-Steroidal Anti-Inflammatory Drugs in Household Drug Supplies in SerbiaKusturica, M. P. / Tomas, A. / Horvat, O. / Bukumiric, Z. / Tomic, Z. / Sabo, A. et al. | 2014
- A416
-
Do Quality or Efficiency Indicators Inside French P4p Perimeter Influence Quality Or Efficiency Indicators Outside P4p?Pichetti, S. / Perronnin, M. / Sermet, C. et al. | 2014
- A417
-
Towards Universal Health Care- A Review of the Basic Basket of Care Associated With Universal Health Care Delivery ModelsBurns, R. M. / Dooley, B. / Armstrong, J. et al. | 2014
- A418
-
Complications, costs And Resource Utilization in Real-World Complex Abdominal Wall Reconstruction PatientsMencer, M. / Reaven, N. / Funk, S. / Franz, M. G. / Macarios, D. / DeNoto, I. I. et al. | 2014
- A419
-
Do Specialty Drugs Offer Greater Value for Money Than Traditional Drugs?Chambers, J. D. / Thorat, T. / Chenoweth, M. / Pyo, J. / Neumann, P. J. et al. | 2014
- A420
-
Constructing A Comorbidity Index According To Iso-Resource ConsumptionSicras-Mainar, A. / Navarro-Artieda, R. et al. | 2014
- A421
-
Pharmaceutical Developpement: Africa an Emergent MarketMahi, L. / Lemdasni, M. / Houari, A. et al. | 2014
- A422
-
Acceptance Of Telemonitoring By Health Care Professionals in Germany: A Question Of Financial ConditionsLeppert, F. / Dockweiler, C. / Eggers, N. / Webel, K. / Hornberg, C. / Greiner, W. et al. | 2014
- A423
-
Home Pharmacies: An Insight In Self-Medication PracticePaut, K. M. / Tomic, Z. / Bukumiric, Z. / Trivic, B. / Sabo, A. et al. | 2014
- A424
-
Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net Tax Revenue for TurkeyKockaya, G. / Tuna, E. / Yenilmez, F. B. / Atikeler, K. / Tatar, M. et al. | 2014
- A425
-
Assessment of Validity of An Indicator Module In Identification of adverse Drug Events in Patients of Medicine DepartmentMallayasamy, S. / Shravya, J. / Mehta, A. / Vilakkathala, R. et al. | 2014
- A426
-
Predicted Versus Actual Budget Impact of High-Cost Drugs In IrelandFogarty, E. / Barry, M. et al. | 2014
- A427
-
Regulatory Approval To Patient Access, An Evaluation of Eu5 And Us National Timing Differences: An UpdateMycka, J. / Dellamano, R. / Lobb, W. / Dalal, N. / Pereira, E. / Dellamano, L. / Sagaydachnaya, O. et al. | 2014
- A428
-
The Reimbursement of Expensive Drugs In Hospitals in Western European CountriesFalk, K. / Brown, A. / Murray, G. / Martensson, M. et al. | 2014
- A429
-
Swisshta Recommendation as an Optimal approach for Pragmatic HTA Evaluations? An International ComparisonWalzer, S. / Droeschel, D. et al. | 2014
- A430
-
Does Not Reaching an Agreement on the Final Nice Scope Have Any Impact on The Final Apraisal Outcome?Casamayor, M. / Heemstra, L. / Van, E. A. et al. | 2014
- A431
-
Evidence-Based Market Access Value Resource: Navigating The Hurdles for A Biologic Obtaining A License In A Second Indication in Key European CountriesHogue, S. / Bjoerk, B. / Walker, A. / Balp, M. M. / Fernandez, M. / Quijano, M. / Ling, C. S. / Heyes, A. E. et al. | 2014
- A432
-
Determination of Referral Utilization Rate: Linking Households To Health Care System; Kenyan Rural Setting ExperienceMogere, D. M. / Loum, C. S. / Kaseje, D. et al. | 2014
- A433
-
Predictors of Working Motivation in Job Satisfaction Among Nurses in CyprusPolyviou, C. / Latsou, D. / Geitona, M. et al. | 2014
- A434
-
What Is The Patients' Median Delay From The Referring Community Health Worker To Arrival in the Link Health Facility?Mogere, D. M. / Loum, C. S. / Kaseje, D. et al. | 2014
- A435
-
Health Care Reform in China And The United States: A Tale of Two Nations Seeking To Improve Access To Affordable CoverageMoore, R. et al. | 2014
- A436
-
Will Value Based Assessment (VBA) Revolutionise The Nice Assessment?Heemstra, L. / Purchase, J. L. / Van, E. A. et al. | 2014
- A437
-
Selection of Topics For Nice Technology Appraisal 2005-2011: What Matters Most?Ward, D. J. / Shiyka, A. / Fellows, R. et al. | 2014
- A438
-
Nice Restrictiveness Compared To the Market AuthorizationJaksa, A. / Westbrook, L. / Rubinstein, E. / Daniel, K. / Ho, Y. S. et al. | 2014
- A439
-
Hta Epidemiology Data in Different Geographical Regions: Investigation of Requirements For Oncology DrugsChadda, S. / Chandler, T. et al. | 2014
- A440
-
Reality in Market Access In Germany and France – Comparative Analysis of Added Benefit Decisions on Innovative Pharmaceutical TherapiesDroeschel, D. / Chicoye, A. / Lepretre, M. et al. | 2014
- A441
-
Exploring Uncertainty in Economic Evaluation Of Medicines: A Review of The First Manufacturers' Submissions To the French National Authority For Health (Has)Ghabri, S. / Hamers, F. F. / Josselin, J. M. / Harousseau, J. L. et al. | 2014
- A442
-
HTA Approach in Italy. Structure, Methods, And Process Of Veneto Region's Evaluation Of Pharmaceutical Effectiveness Unit (Unità Di Valutazione Dell'efficacia Del Farmaco, Uvef)Young, K. E. / Urbinati, D. / Toumi, M. et al. | 2014
- A443
-
Transferability of Economic Evaluations To Central and Eastern Euroepan and Former Soviet CountriesMandrik, O. / Knies, S. / Kaló, Z. / Severens, J. L. et al. | 2014
- A444
-
Is G-Ba Strategically Discounting The Benefit Assessment of Relatively High Cost Drugs?Jaksa, A. / Daniel, K. / Bergemann, R. / Ho, Y. S. et al. | 2014
- A445
-
The Costs and Effects of Post-Authorisation Safety Studies For New Active SubstancesBouvy, J. C. / De Bruin, M. L. / Hoekman, J. / Stolk, P. et al. | 2014
- A446
-
Breastfeeding and Its Effect On The Probability of Occurance of the Probability of Occurance of the Disease And Related CostsLehocká, L. / Malovecká, I. / Minariková, D. / Foltan, V. et al. | 2014
- A447
-
Impacts Of Bar-Code Medication Administration (Bcma) On Patients' Safety in TaiwanLee, M. et al. | 2014
- A448
-
The Comparison of the Risk-Sharing Schemes Proposed in Reimbursement Applications Received By Ahtapol In 2012 and 2013Zawodnik, S. / Iwanczuk, T. / Hermanowski, T. R. / Matusewicz, W. et al. | 2014
- A449
-
National Immunisation Technical Advisory Groups - A Framework For Assessment and Insights From ResearchKleintjens, J. / King, S. / Hernández-Pastor, L. J. / Abels, M. / Saka, . / Bichon, J. et al. | 2014
- A450
-
Market Access and Reimbursement: The Increasing Role of Real-World EvidencePietri, G. / Masoura, P. et al. | 2014
- A451
-
An Ethic System Overview: Brazilian Perspectives For Observational StudiesMinowa, E. / Bueno, C. C. / Piedade, A. / Clark, L. G. / Santinho, C. S. / de Castro Monteiro, D. C. / Feijo, L. F. / Ueda, K. / Matos, G. M. / Hashimoto, D. A. et al. | 2014
- A452
-
Market Access and Reimbursement Options For Orphan Durg Hospital Only Medicines In Europe – One Size Fits All?Vosgerau, S. / Paulus, G. / Plantoer, S. et al. | 2014
- A453
-
Efficacy of the Phosphorylated Tau P181 for the Alzheimer's Disease Dementia - a Systematic Review and Meta AnalysisMo, J. et al. | 2014
- A454
-
Network Meta-Analysis of the Relative Efficacy of Pharmacological and Psychological Interventions in Adults with Obsessive Compulsive DisorderBryden, P. A. / Caldwell, D. M. / Welton, N. / Churchill, R. / Baxter, H. / Lewis, G. / Skapinakis, P. et al. | 2014
- A455
-
The Prevalence and Disease Burden of Treatment-Resistant Depression - a Systematic Review of the LiteratureKubitz, N. / Vossen, C. / Papadimitropoulou, K. / Karabis, A. et al. | 2014
- A456
-
Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims DatabaseKellar, J. / Mittmann, N. / von Heymann, C. / Zingaro, J. / Kuriakose, B. / Li, A. et al. | 2014
- A457
-
Aripiprazole Once-Monthly is a Cost-Effective Therapeutic Option in the Maintenance Treatment of Schizophrenia: Results from a Markov ModelSapin, C. / Tempest, M. J. / Gaughran, F. / Beillat, M. / Robinson, P. / Treur, M. et al. | 2014
- A458
-
The Cost Effectiveness of Group Art Therapy for Patients with Non-Psychotic Mental Health Disorders in England And WalesStevenson, M. / Rawdin, A. / Uttley, L. / Sutton, A. et al. | 2014
- A459
-
Cost-Effectiveness of Paliperidone Palmitate Versus other Antipsychotics for the Treatment of Schizophrenia in FranceDoutriaux, A. / Cognet, M. / Druais, S. / Lançon, C. / Samalin, L. / Levy, P. / Godet, A. / Guillon, P. et al. | 2014
- A460
-
Adherence to Psychotropic Medications by Outpatients in Psychiatric Hospital, Uselu Benin City, NigeriaArute, J. E. / Eniojukan, J. F. / Eboigbe, N. P. et al. | 2014
- A461
-
The Anxiety Inventory for Respiratory Disease (Air): an Exploration of the Air's Psychometric Properties Through Rasch AnalysisWillgoss, T. G. / Humphrey, L. / Fatoye, F. / Yohannes, A. M. et al. | 2014
- A462
-
Alcohol Consumption: the Burden of EntourageTouboul, C. / Hoertel, N. / Limosin, F. / Crochard, A. / Rouillon, F. et al. | 2014
- A463
-
Comparison of Health Care Resource use and Costs in Patients with Opioid Prescription Drug Dependence (Opd) Treated with Buprenorphine/Naloxone and Patients without Pharmacological Treatment: Retrospective Analysis of us Public Insurance ClaimsKhemiri, A. / Clay, E. / Kharitonova, E. / Aballéa, S. / Zah, V. / Ruby, J. et al. | 2014
- A464
-
Analysis of Prescribing Patterns of Atypical Antipsychotics in Lhu CasertaFarina, G. / Menditto, E. / Manna, S. / Pagliaro, C. / Troncone, C. / Putignano, D. / Orlando, V. / Linguiti, C. / Buffardi, G. F. / Tari, M. G. et al. | 2014
- A465
-
Population Health: Mental Health of us Veterans by Benefits Enrollment StatusRichardson, T. / Claeys, C. / Sastry, P. et al. | 2014
- A466
-
Comparative Effectiveness Of Automated Versus Continuous Ambulatory Peritoneal Dialysis On Patients With End-Stage Renal Disease In TaiwanTang, C. H. / Sue, Y. M. / Wu, Y. T. / Huang, S. Y. et al. | 2014
- A467
-
An Economic Model To Investigate The Budget Impact In Spain Of Onabotulinumtoxina To Manage Urinary Incontinence In Patients With Idiopathic Overactive BladderRuff, L. / Zeidman, R. / Aracil, J. / Loveman, C. et al. | 2014
- A468
-
Cost Consequence Analysis Of Darbepoetin Alfa For The Treatment Of Anemia Due To Chronic Kidney Disease (Ckd) In GreeceKourlaba, G. / Boletis, I. / Goumenos, D. / Iatrou, C. / Papagiannopoulou, V. / Tritaki, G. / Maniadakis, N. et al. | 2014
- A469
-
Cost-Effectiveness Of Mycophelonate Sodium On Patients With Renal Transplant At The Public Mexican Health Care SystemRuiz, M. C. / Ubiarco, L. V. et al. | 2014
- A470
-
Burden On Secondary Care Of Overactive Bladder Patients Who Are Inadequately Managed With Anticholinergics In EnglandHamid, R. / Loveman, C. / Morton, R. / Millen, J. / Hassan, Y. et al. | 2014
- A471
-
Health-Related Quality Of Life And Subjective Happiness Of Patients With Benign Prostatic Hyperplasia: First Results Of A Cross-Sectional Survey From HungaryRencz, F. / Kovács, . / Gulacsi, L. / Majoros, A. / Nyirády, P. / Tenke, P. / Németh, Z. / Nagy, G. J. / Nagy, J. / Buzogány, I. et al. | 2014
- A472
-
Readmittance To Hospital Within 6 Months After A Venous Thromboembolism Event: Prefer In Vte RegistryBauersachs, R. / Gitt, A. K. / Mismetti, P. / Monreal, M. / Willich, S. N. / Wolf, W. P. / Agnelli, G. / Cohen, A. T. et al. | 2014
- A473
-
Development Of A Collaborative European Pharmacoepidemiologic Post-Authorization Safety Study (Pass) Programme Examining Rivaroxaban Use In Routine Clinical PracticeBrobert, G. / García, R. g. / Garbe, E. / Bezemer, I. D. / Layton, D. / Friberg, L. / Suzart-Woischnik, K. / Alderson, J. / Winchester, C. / Herings, R. M. et al. | 2014
- A474
-
The Use Of Minimally Invasive Surgery (Mis) And Intraoperative Imaging Modalities In The Treatment Of Intracerebral Hemorrhage (Ich): A Systematic Review Of The LiteratureKaramalis, M. / Langer, K. / Demessinov, A. / Birinyi-Strachan, L. et al. | 2014
- A475
-
Critical Appraisal Of Network Meta-Analyses Evaluating The Efficacy And Safety Of New Oral Anticoagulants In Atrial Fibrillation Stroke Prevention TrialsCope, S. / Clemens, A. / Hammès, F. / Noack, H. / Jansen, J. et al. | 2014
- A476
-
A Database Analysis Of Patients Eligible For Second-Line Lipid-Lowering Treatment For Hypercholesterolaemia In EnglandAmber, V. / Jameson, K. / Das, R. / Baxter, C. / Watson, L. et al. | 2014
- A477
-
Retrospective Analysis On Hospitalization And Health Care Costs, According To Serum Uric Acid Levels In Patients From A Sample Of Italian Local Health UnitsDegli, E. L. / Saragoni, S. / Buda, S. / Desideri, G. / Borghi, C. et al. | 2014
- A478
-
Budgetary Impact Analysis Of Reimbursement Varenicline In The Smoking Cessation Treatment Of Patients With Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease Or Type-2 Diabetes Mellitus: A National Health System Perspective In SpainRejas, G. r. / Sicras, M. A. / Navarro, A. R. / De, L. J. et al. | 2014
- A479
-
Budget Impact Analysis Of Botulinum Toxin A Therapy For Upper Limb Spasticity In GermanyZoellner, Y. F. / Gerwe, M. / Richter, M. et al. | 2014
- A480
-
The Move Towards Full Implementation Of The Nice Guidelines For Stroke Prevention In Atrial Fibrillation: The Potential Cost And Clinical ImpactShields, G. E. / Chapman, A. M. et al. | 2014
- A481
-
Goal Directed Perfusion (Gdp): A Differential Cost Analysis In Uk And UsPovero, M. / Pradelli, L. et al. | 2014
- A482
-
Economics And Clinical Evaluation Of Endovascular And Surgical Treatment Of Patients With Disability Of Superficial Femoral ArteryKamensky, V. / Ivlev, I. et al. | 2014
- A483
-
The Economic Impact Of Cardiovascular Events In Patients Post Myocardial Infarction: Uk Health Care PerspectiveJain, M. / Sonathi, V. / Rathi, H. / Thomas, S. K. / Mollon, P. et al. | 2014
- A484
-
Cost Of Bleeding In Trauma PatientsZbrozek, A. et al. | 2014
- A485
-
Does A 12-Lead Ecg More Reliably Detect Atrial Fibrilation Than A Rhythm Strip Only Ecg?Vyas, V. / Duran, J. / Ansaripour, A. / Niedzielko, M. / Steel, A. / Bakhai, A. et al. | 2014
- A486
-
Pharmacoeconomic Assessment Of Apixaban Versus Standard Of Care For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation PatientsPradelli, L. / Calandriello, M. / Di, V. R. / Bellone, M. / Tubaro, M. et al. | 2014
- A487
-
Cost Effectiveness Analysis Of Apixaban Versus Other Noacs For The Prevention Of Stroke In Italian Non-Valvular Atrial Fibrillation PatientsPradelli, L. / Calandriello, M. / Di, V. R. / Bellone, M. / Tubaro, M. et al. | 2014
- A488
-
A Cost-Effectiveness Analysis Of Interventions For Symptomatic Varicose VeinsMarsden, G. / Perry, M. / Bradbury, A. / Hickey, N. / Kelley, K. / Trender, H. / Wonderling, D. / Davies, A. H. et al. | 2014
- A489
-
Economic Evaluation Of Valsartan Versus Olmesartan Addition To Amlodipine And Hydrochlorothiaziade Single-Pill Triple Antihypertensive TherapyStafylas, P. / Mavrodi, A. / Kourlaba, G. / Hatzikou, M. / Rombopoulos, G. / Maniadakis, N. et al. | 2014
- A490
-
Cost Model Analysis Of Gore® Propaten® Vascular Graft Verse. Standard Eptfe Vascular Graft For Infrapopliteal Bypass In Peripheral Arterial Disease (pad) Management: Spanish ScenarioScarpa, F. et al. | 2014
- A491
-
Burden Of Hyperlipidemia Resulting From Productivity Loss - Estimates From Population-Based Register Data In SwedenBanefelt, J. / Hallberg, S. / Gandra, S. R. / Mesterton, J. / Fox, K. M. / Paoli, C. J. / Johansson, G. / Levin, L. / Sobocki, P. et al. | 2014
- A492
-
Understanding Medication Adherence Using Stated-Preference DataGonzález, J. M. / Poulos, C. / Mollon, P. et al. | 2014
- A493
-
Health State In Patients With Venous Thromboembolism On Conventional And Non-Vka Oral Anticoagulants As Assessed With The Eq-5d-5l Questionnaire: Prefer In Vte RegistryCohen, A. T. / Bauersachs, R. / Gitt, A. K. / Mismetti, P. / Monreal, M. / Willich, S. N. / Wolf, W. P. / Agnelli, G. et al. | 2014
- A494
-
Beliefs About Medicines In An Urban Black Hypertension PopulationBarr, J. / Callender, S. / Tung, D. / Fashote, B. / Lacroix, L. / Young, A. et al. | 2014
- A495
-
Literature Review Of Pro Measures Assessing Anticoagulant TherapyBarrett, A. M. / Harris, N. I. / DeMuro, C. / Kachroo, S. / Phatak, H. et al. | 2014
- A496
-
Treatment Satisfaction In Patients With Venous Thromboembolism As Measured With Pact-Q2: Prefer In Vte RegistryWillich, S. N. / Bauersachs, R. / Gitt, A. K. / Mismetti, P. / Monreal, M. / Wolf, W. P. / Agnelli, G. / Cohen, A. T. et al. | 2014
- A497
-
The Clinical Impact Of Rivaroxaban To Chinese At Deep Vein Thrombosis Patients Results From A Simple Communication ToolYang, L. / Wu, J. J. / Zhu, G. / Evers, T. et al. | 2014
- A498
-
The Impact Of Pharmaceutical Policies On Pharmaceutical Sales Patterns In Sweden And JapanImai, S. / Andersson, S. K. / Fushimi, K. et al. | 2014
- A499
-
Initiation of Oral Anticoagulant Drugs: Identification of Drivers of Prescribing of New Agents Versus WarfarinSpillane, S. / Bennett, K. / Barry, M. et al. | 2014
- A500
-
Clinical and Demographics Characteristics of Non-Valvular Atrial Fibrillation Patients Switching From Warfarin To Novel Oral AnticoagulantsKachroo, S. / Pan, X. / Liu, L. / Kawabata, H. / Phatak, H. et al. | 2014
- A501
-
Catastrophic Health Expenditures and Chronic Condition Patients in GreeceSkroumpelos, A. / Pavi, E. / Pasaloglou, S. / Kyriopoulos, J. et al. | 2014
- A502
-
Optimizing Process Efficiency Through Implanting Reveal Linq Verse Reveal Xt/Dx From Three Spanish Hospital PerspectiveEgea García, M. / Toquero, R. J. / García, A. A. / Arias, P. M. / Marti, S. n. et al. | 2014
- A503
-
Health Care Stakeholders' Evaluation of A User-Friendly Tool Which Estimates Long-Term Health Gains Following the Reduction of Ldl LevelsLaires, P. et al. | 2014
- A504
-
Ldl-C Lowering Efficacy of Evolocumab (Amg 145) Could Reduce Apheresis in Patients At High Risk for Cardiovascular Events in GermanyVilla, G. / Schmid, T. / Lothgren, M. / Michailov, G. et al. | 2014
- A505
-
labour induction with prostaglandins: what works best? A systematic review, network meta-analysis and cost-effectiveness analysisKeeney, E. / Alfirevic, Z. / Caldwell, D. M. / Dowswell, T. / Dias, S. / Jones, L. / Navaratnam, K. / Welton, N. J. et al. | 2014
- A506
-
Economic Assessment of Preeclampsia: Screening, Diagnosis, Treatment Options, and Long Term Outcomes, A Systematic ReviewZakiyah, N. / van, A. A. / Baker, P. / Postma, M. J. et al. | 2014
- A507
-
Incidence and Long-Term Cost of Oral Steroid-Related Adverse Events in Chronic Diseases in PolandGarbacka, M. / Zapalska, A. / Borowiack, E. / Tronczyñska, D. / Wepsiec, K. / Dziurda, D. / Krzyzanowska, A. et al. | 2014
- A508
-
Cost Effectiveness Analysis of A Vaccination Programme for the Prevention of Herpes Zoster and Post-Herpetic Neuralgia in Adults Aged 65 and Over in NorwaySuseg, P. / Olsen, D. / Préaud, E. / Uhart, M. et al. | 2014
- A509
-
Cost-Effectiveness Analysis of Screening Syphilis Among Pregnant WomenChuluunbaatar, E. et al. | 2014
- A510
-
Cost-Effectiveness Analysis of the New Biomarkers for Diagnosis of Acute Kidney Injury in Children After Cardiac SurgeryBogavac, S. N. / Petrovic, S. / Lakic, D. / Peco, A. A. / Vulicevic, I. / Ivanisevic, I. / Kotur, S. J. / Jelic-Ivanovic, Z. et al. | 2014
- A511
-
Cost-Utility Analysis of A Medication Review With Follow-Up for Older People With Polypharmacy in Community Pharmacies in Spain: Consigue ProgramJódar-Sánchez, F. / Malet-Larrea, A. / Martín, J. / Garcia, L. / López, d. A. / Martínez-Martínez, F. / Gastelurrutia-Garralda, M. A. / Garcia-Cárdenas, M. V. / Sabater-Hernández, D. / Benrimoj, S. I. et al. | 2014
- A512
-
Patients' Acceptance of Their Medication: Results From a French Multi-Diseases Study With Patient Online Community Using the Acceptance By the Patients of Their Treatment (Accept©) QuestionnaireGilet, H. / Chekroun, M. / Arnould, B. et al. | 2014
- A513
-
Geographical Variations of Health Perception in the Us, Using Brfss Data 2012Duccini, F. D. / Roïz, J. et al. | 2014
- A514
-
Reference Eq-5d-3l and Eq-5d-5l Data From the Italian General PopulationScalone, L. / Cortesi, P. A. / Mantovani, L. G. / Ciampichini, R. / Cesana, G. et al. | 2014
- A515
-
A Systematic Review To Identify the Use of Preference Elicitation Methods in Health Care Decision MakingJanus, S. I. / Weernink, M. G. / van Til, J. A. / Raisch, D. W. / van Manen, J. G. / IJzerman, M. J. et al. | 2014
- A516
-
Assessing the Translatability of the Term “Frustrated”McKown, S. / Angun, C. / Talbert, M. / Brandt, B. A. / Gawlicki, M. C. et al. | 2014
- A517
-
The Endometriosis Health Profile (Ehp) – A Case Study of Successful Epro CollaborationTwo, R. / Wilkins, G. / Cox, A. / Jenkinson, C. / McEvoy, K. / Churchman, D. / Walzer, A. / Wichmann, K. et al. | 2014
- A518
-
Hospital Drg Costing and Health Services Use of Very Pre-Term Infants From the Proprems Neuro Study Across 10 Hospitals in Australia and New ZealandSia, K. L. / Gold, L. / Jacobs, S. / Cheong, J. / Opie, G. / Garland, S. / Donath, S. / Hickey, L. / Boland, R. / Webster, C. et al. | 2014
- A519
-
Evaluation of Patient and Financial Outcomes Associated With Advanced Infertility Treatment OptionsLocklear, J. / Bozkaya, D. / Migliaccio, K. / Bramley, T. / Phillips, A. L. / Mahony, M. et al. | 2014
- A520
-
Predictions for Medical Subsidy Enrollment Among Young Children From High-Risk Families in TaipeiLussier, E. C. et al. | 2014
- A521
-
Pain Incidence and Analgesic Consumption During Haemodialysis Sessions: Impact on Health-Related Quality Of LifeRebollo, P. / Arenas, M. D. / Castejón, N. / Reichert, G. a. / Delgado, C. P. / Gutierrez, R. P. / Gil, G. l. et al. | 2014
- A522
-
Comparison of Disease Status and Outcomes of Patients With Ankylosing Spondylitis (As) Receiving Adalimumab Or Etanercept Monotherapy In EuropeNarayanan, S. / Lu, Y. / Hutchings, R. / Baynton, E. et al. | 2014
- A523
-
How To Improve Health Outcomes In the Treatment of Chronic Myeloid LeukemiaViriato, D. / Marques, A. / Fonseca, M. / Almeida, A. et al. | 2014
- A524
-
The Presence of Anxiety Among Elementary Schools Obese ChildrenGermán, Z. / Botár, A. / Sziládiné, F. K. / Pakai, A. / Boncz, I. / Fullér, N. / Oláh, A. et al. | 2014
- A525
-
Budget Impact Analysis of Belimumab In the Treatment of Patients With Systemic Lupus Erythematosus In Russian FederationKulikov, A. / Komarov, I. / Pochuprina, A. et al. | 2014
- A526
-
Economic Considerations On the Use of Mifamurtide In the Treatment of Osteosarcoma In SpainBrosa, M. / García, d. M. / Mora, J. / Villacampa, A. / Pozo, T. / Adán, C. / Grande, M. / García, E. / Cubells, L. et al. | 2014
- A527
-
Rates of Diagnosed Opioid Abuse Or Dependence and Incremental Direct Health Care Costs Among Patients With Long-Term Use of Immediate Release HydrocodoneBenJoseph, R. / Yang, E. / Huse, S. / Bhagnani, T. D. / Holly, P. / Kansal, A. et al. | 2014
- A528
-
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In PolandMocko, P. / Kawalec, P. et al. | 2014
- A529
-
Direct and Indirect Costs Associated With Increasing Body Mass Index (Bmi) In the Eu5Richard, L. / Gupta, S. / Pomerantz, D. / Forsythe, A. et al. | 2014
- A530
-
Cost-Effectiveness Analysis of Maintenance Treatment With Rituximab In Patients With Follicular Lymphoma Responding To First Line Induction Therapy In PortugalPereira, C. / Rubio, T. C. / Rubio, R. g. et al. | 2014
- A531
-
Cost-Effectiveness Analysis of Amfepramone (Diethylpropion) for the Obesity Treatment In MexicoSoto, M. H. / Díaz, M. n. / Escobar, J. r. / Fernández, d. V. et al. | 2014
- A532
-
Belimumab for the Treatment of Systemic Lupus Erythematosus (Sle) In Greece: A Cost-Effectiveness and Cost-Utility AnalysisAthanasakis, K. / Karampli, E. / Ollandezos, M. / Igoumenidis, M. / Karabela, P. / Psomali, D. / Kyriopoulos, J. et al. | 2014
- A533
-
Cost-Minimization Analysis of Methadona Opioid Analgesic for Mexican Patients With Acute and Chronic Secondary Cancer As Rotation Option In Severe PainSoto, M. H. / Sanchez, K. / Constanzo, A. / Escobar, J. r. / Fernandez, Z. / Melendez, C. et al. | 2014
- A534
-
New Observer-Reported Outcomes To Measure Treatment Satisfaction, Compliance, Palatability, and Gi Symptoms for Patients Needing Iron-Chelation TherapyLasch, K. / Horodniceanu, E. G. / Carter, J. A. / Dhatt, H. / Bal, V. / Côté, I. / Constantinovici, N. / Herranz, R. M. / Malet, I. et al. | 2014
- A535
-
Prevalence of Neuropathic Pain and Its Disease Burden In Korea Patients With Lumbar Spine SurgeryCho, Y. E. / Moon, S. H. / Whang, C. J. / Kim, H. J. et al. | 2014
- A536
-
Evaluating Relationship Between White Blood Cells and Platelets During Recovery Phase In Dengue Hemorrhagic Fever Cases In Punjab, Pakistan: A Retrospective StudyRasool, F. / Ahmad, M. / Masood, I. / Khan, H. M. et al. | 2014
- A537
-
Patient-Reported Outcomes In Moderate To Severe Hemophilia Patients: Finding From A Cross-Sectionalstudy In KoreaLee, K. S. / Cha, J. H. et al. | 2014
- A538
-
The Quality of Life of Patients Treated With Robotic Versus Traditional Surgery Results From An Italian Observational Multicenter StudyTurchetti, G. / Pierotti, F. / Palla, I. / Manetti, S. / Cuschieri, A. et al. | 2014
- A539
-
Comparative Analysis of Hta Decisions, Price and Reimbursement Level of Orphan Drugs In France and ItalyKorchagina, D. / Tavella, F. / Rémuzat, C. / Kornfeld, A. / Toumi, M. et al. | 2014
- A540
-
Top 20 Orphan Drugs Availability, Pricing and Reimbursement In Slovakia: 2005-2012 ReviewBabela, R. / Uraz, V. / Babelova, O. / Slezakova, Z. et al. | 2014
- A541
-
Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs: A Dutch Demonstration Study Using the Analytic Hierarchy Process MethodTrip, A. M. / Tsiachristas, A. / Koenders, J. M. / Kanters, T. A. et al. | 2014
- A542
-
Variations In Treatment Patterns and Disease Severity Among Patients With Psoriasis Receiving Their First Biologic Therapy In Europe (Eu)Narayanan, S. / Franceschetti, A. et al. | 2014
- A543
-
Treatment Effect Heterogeneity in Clinical Trials: An Evaluation of 13 Large Clinical Trials Using Individual Patient DataKent, D. M. / Nelson, J. / Altman, D. G. / Hayward, R. A. et al. | 2014
- A544
-
Assessing the Relationship Between Treatment Effect and Baseline Risk in Network Meta-Analsysis of Moderate to Severe Chornic Plaque Psoriasis TrialsSmiechowski, B. / Cope, S. et al. | 2014
- A545
-
Comparative Real World Effectiveness of Novel Agents Versus Conventional Therapies in Multiple Myeloma Patients in SwedenThilakarathne, P. / Diels, J. / van Sanden, S. / Liwing, J. / Van Agthoven, M. / Chirita, O. / Nahi, H. et al. | 2014
- A546
-
Predictive Modelling for Optimal Target Population and Real-World Study Design: An Example In Mother-To-Child Transmission of HIVAmzal, B. et al. | 2014
- A547
-
Validation of The Hospital Episode Statistics Outpatient Dataset in EnglandThorn, J. C. / Turner, E. / Hounsome, L. / Walsh, E. / Down, L. / Donovan, J. / Verne, J. / Neal, D. / Hamdy, F. / Martin, R. M. et al. | 2014
- A548
-
Proposal for a Comprehensive Definition of Budget Impact AnalysisBierbaum, M. et al. | 2014
- A549
-
Cost-Effectiveness Analysis of Ipilimumab in Previously Untreated Patients With Unresectable Malignant Melanoma in ScotlandLee, D. / Porter, J. / Hatswell, A. J. / Hertel, N. / Walker, A. et al. | 2014
- A550
-
A Review of The Utility Values Used in Published Cost-Effectiveness Analyses of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Therapy in Patients With Diabetic NephropathyPaczkowski, R. / Kennedy-Martin, T. / Rayner, S. et al. | 2014
- A551
-
An Efficient Design for Cost-Effectiveness Studies of Personalized Medicine StrategiesLeunis, A. / Redekop, W. K. / Lowenberg, B. / Uyl-De Groot, C. A. et al. | 2014
- A552
-
Adopting an Evidence Synthesis Approach for Assessing Cost-Effectiveness of Screening Strategies for Prostate Cancer in IrelandBurns, R. M. / Leal, J. / Wolstenhome, J. / O'Neill, C. / Sullivan, F. J. / Drummond, F. J. / Sharp, L. et al. | 2014
- A553
-
Using an Innovative Approach to Build a Prospective Diabetes Cohort Registry of Patients With Type 2 Diabetes in Germany: DIAREGGarcia Alvarez, L. / Rathmann, W. / Bode-Greuel, K. / Engelhard, J. / Bush, S. / Schröder-Bernhardi, D. / Hiller, J. et al. | 2014
- A554
-
Common Pregnancy Symptoms Increase the Risk Of Cardiovascular DiseaseZulkifly, H. / Dingle, K. / Clavarino, A. et al. | 2014
- A555
-
Creating Patient Profile in Individual Simulations: A Comparison of ApproachesStern, S. / Pan, F. et al. | 2014
- A556
-
Advishe: a New Tool to Report Validation of Health-Economic Decision ModelsVemer, P. / Corro Ramos, I. / Van Voorn, G. / Al, M. J. / Feenstra, T. L. et al. | 2014
- A557
-
Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (COPD): Cross-Model Comparison of Hypothetical Treatment ScenariosHoogendoorn, M. / Feenstra, T. / Asukai, Y. / Borg, S. / Hansen, R. N. / Jansson, S. A. / Samyshkin, Y. / Wacker, M. / Briggs, A. / Lloyd, A. et al. | 2014
- A558
-
A Comparison of Modelling Techniques: Patient Simulation Verse Markov Modelling in OphthalmologyClaxton, L. / Malcolm, W. A. / Hodgson, R. et al. | 2014
- A559
-
Clinical Trial Simulation Considering Quality Of Life OutcomesMohseninejad, L. / Heeg, B. / Majer, I. M. et al. | 2014
- A560
-
Validating A Model To Predict Disease Progression Outcomes In Patients With COPDRisebrough, N. A. / Briggs, A. / Baker, T. M. / Exuzides, A. / Colby, C. / Rutten van-Molken, M. / Gonzalez McQuire, S. / Lomas, D. / Muellerova, H. / Tal-Singer, R. et al. | 2014
- A561
-
How Does Uncertainty Around Costs And Effects Relate To Uncertainty Around Cost-Effectiveness?Jain, M. / Bhattacharyya, S. / Gupta, S. / Sonathi, V. / Mahon, R. / Malakar, H. / Vudumala, U. / Gunda, P. / Kumar, P. / Partha, G. et al. | 2014
- A562
-
Methodological Evaluation Of The Impact Of Survival Costs In Oncology ModellingTaylor, M. / Filby, A. / Proudfoot, C. et al. | 2014
- A563
-
Modelling Evolving Cancer Risk During Epidemiological Transition Using Economic DataHughes, M. / Seesaghur, A. / De Silva, D. et al. | 2014
- A564
-
Stratified Cost-Effectiveness Analysis To Guide Genetic Screening For Cancer RiskFolse, H. J. / Dinh, T. et al. | 2014
- A565
-
MODELLING HEALTH-RELATED QUALITY OF LIFE (HRQOL) LONGITUDINALLY. A BAYESIAN MIXED BETA REGRESSION APPROACHGheorghe, M. / Brouwer, W. / van Baal, P. et al. | 2014
- A566
-
Joint Modelling Of The Change In Tumor Size And Overall Survival; A Parametric Model Considering Patient Heterogeneity Not Observed At BaselineMajer, I. M. / Heeg, B. et al. | 2014
- A567
-
How Do Individuals Complete The Choice Tasks In A Discrete Choice Experiment?Veldwijk, J. / Determann, D. / Lambooij, M. S. / van Til, J. A. / Korfage, I. J. / de Bekker-Grob, E. / de Wit, G. A. et al. | 2014
- A568
-
Validity And Responsiveness Of The Bristol Rheumatoid Arthritis Fatigue Multidimensional Questionnaire (BRAF-MDQ) In A Randomized Controlled Clinical TrialKirwan, J. / Coteur, G. / Dures, E. / Nicklin, J. / Bryson, J. / Hewlett, S. et al. | 2014
- A569
-
Predicting Suicidal Behavior In Veterans And Active Military Personnel: Possibilities For Electronic Deployment To Discover A Predictive AssessmentSage, C. C. / Platko, J. V. / Nokela, M. et al. | 2014
- A570
-
Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease: Interim Results from the Sole StudyLazzaro, C. / Cappello, M. / Cortelezzi, C. / Costantino, G. / Fiorino, G. / Mastronardi, M. / Giannotta, M. / Galletti, B. / Cicala, M. / Vadalà di Prampero, S. et al. | 2014
- A571
-
Improving Performance in Diabetes Care: Benefits of Information Technology Enabled Diabetes ManagementSaric, T. / Lazic, G. / Poljicanin, T. / Prenda, T. T. et al. | 2014
- A572
-
Quality of Life Elements in Schizophrenia for Patients and Carers offer Challenges To and Opportunities for InterventionFloyd, D. / Gemmell, E. / Brown, J. et al. | 2014
- A573
-
An Analysis of the Health Technology Assessment Recommendation and Guidance on Use of Eq-5d-5l in Cost-Effectiveness ModelingOvcinnikova, O. / Firth, Z. A. / Dimova, M. et al. | 2014
- A574
-
Impact of Osteoporotic Fractures on Quality of Life – Design of A Mapping Study of Qualiost To Eq-5dHansen, L. / Vestergaard, P. / Petersen, K. D. et al. | 2014
- A575
-
Methods To Elicit Patient Preferences: A Case Study In Metastatic Breast CancerCopher, R. / DiBonaventura, M. / Basurto, E. / Faria, C. / Lorenzo, R. et al. | 2014
- A576
-
The Use and Acceptance of Novel Statistical Analyses To Support Technology Submissions To Hta AuthoritiesBatson, S. / Mitchell, S. A. / King, D. et al. | 2014
- A577
-
Graphical Interactive Meta-Analysis Module for Facilitating Evidence-Based Decision Making in Health CareSpata, E. / Bujkiewicz, S. et al. | 2014
- A578
-
Knowledge on Medication Taking Behaviour, Balanced Diet and Physical Activity - A Survey Among the Adolescentssandeep, C. K. / Nallani, V. R. et al. | 2014
- A579
-
Proposed Checklist for Non-Statisticians To Assess the Quality of A Network Meta-Analysis in the Context of A Nice SubmissionPacou, M. / Gauthier, A. / Taieb, V. / Bec, M. / Belhadi, D. / Guillemot, J. et al. | 2014
- A580
-
Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Code Is Not Available: A Validation Study Comparing Medication/Prescriber Visit Based Algorithms To Diagnosis CodesDobson-Belaire, W. / Borrelli, R. / Goodfield, J. / Liu, F. F. / Khan, Z. M. et al. | 2014
- A581
-
Immature Survival Data From Early Trial Termination – Theory and Hta PracticePruefert, A. / Skaltsa, K. / Maervoet, J. / Van, E. A. et al. | 2014
- A582
-
(Cost-) Effectiveness of A Multi-Component Intervention for Adults With Epilepsy: Study Protocol of A Dutch Randomized Controlled TrialWijnen, B. / Leenen, L. A. / de, K. R. / Majoie, M. H. / van, H. C. / Evers, S. M. et al. | 2014
- A583
-
Towards Integration of Research Evidence on Patient Preferences in Coverage Decisions and Clinical Practice Guidelines: A Proposal for A Taxonomy of Preference-Related TermsUtens, C. M. / Joore, M. A. / van, d. W. / Dirksen, C. D. et al. | 2014
- A584
-
Effective Prioritisation of National Health Technology AssessmentsMoran, P. / Harrington, P. / Ryan, M. et al. | 2014
- A585
-
Evaluation of Estimators of Treatment Effect in Observational StudiesFaries, D. E. / Lipkovich, I. / Kadziola, Z. et al. | 2014
- A586
-
Challenges In Meeting Evidence Needs Of Payer, Physician, Patient And Industry Stakeholders For Novel TherapeuticsPauer, L. et al. | 2014
- A587
-
Real World Studies, Challenges, Needs and Trends from the IndustryBatrouni, M. / Comet, D. / Meunier, J. P. et al. | 2014
- A588
-
Comparative Efficacy of Umeclidinium Bromide Versus Other Long-Acting Anticholinergic Monotherapies as Treatments for Copd PatientsIsmaila, A. / Huisman, E. / Punekar, Y. S. et al. | 2014
- A589
-
A Database Study to Investigate the Incidence of Anaphylaxis and the Prescription Rate of Self-Injection Epinephrine in JapanShima, D. / Ii, Y. / Yamamoto, Y. / Nagayasu, S. / Fujimoto, Y. et al. | 2014
- A590
-
Current Annual Cost Calculation is the Best Predictor of Mortality at Three Years in COPDDal negro, R. et al. | 2014
- A591
-
Estimation of Increased Costs in Switching from Tiotropium to Other Lama Therapy During Maintenance Treatment of COPD in the UKTernouth, A. / Schoenherr, N. / Edwards, S. C. et al. | 2014
- A592
-
Examination of the Burden of Illness of U. S. Medicare Patients Diagnosed with Chronic Obstructive Pulmonary DiseaseXie, L. / Kariburyo, M. F. / Du, J. / Baser, O. et al. | 2014
- A593
-
Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in RussiaKrysanova, V. / Krysanov, I. et al. | 2014
- A594
-
Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in SlovakiaOndrusova, M. / Psenkova, M. / Mackovicova, S. et al. | 2014
- A595
-
Cost Effective Analysis of Dry Powdered Inhalers Versus Metered Dose Inhalers of Salbutamol for Asthma in Rural Secondary Care Hospital of South IndiaVigneshwaran, E. / Maddirevula, M. R. / Dharmareddy, L. / Thamineni, R. / Kadapala, P. R. / Golla, M. / Yiragamreddy, P. R. et al. | 2014
- A596
-
Cost-Effectiveness of Asthma Management in a Hospital-Based Adult Asthma Clinic in SpainPerez de Llano, L. A. / Villoro, R. / Hidalgo, A. / Merino, M. et al. | 2014
- A597
-
Economic Evaluation of Omalizumab Compared With Standard Therapy in the Treatment of Severe Allergic Asthma in Adult Patients in Greece: a Cost Effectiveness Analysis Based on Clinical Trial and Real-World DataSonathi, V. / Hatzikou, M. / Baldwin, M. / Panitti, E. / Tzortzaki, E. et al. | 2014
- A598
-
The Potential Societal Cost Benefits of Improved Inhalation Technique With Duoresp® Spiromax® (Budesonide + Formoterol Fumarate Dihydrate) Compared With Symbicort® Turbuhaler® for the Management of Asthma and Chronic Obstructive Pulmonary Disease in SwedenLewis, A. / Blackney, M. / Torvinen, S. / Lindqvist, F. / Safioti, G. / Grundström, J. / Polyzoi, M. / Plich, A. et al. | 2014
- A599
-
Tecepoc II Study. How to Improve the Inhalation Techniques in Patient with Copd. The Influence of PreferencesBarnestein-Fonseca, P. / Vazquez-Alarcon, R. / Leiva-Fernandez, F. / Aguiar-Leiva, V. / Lobnig-Becerra, M. / Leiva-Fernandez, J. et al. | 2014
- A600
-
Testing E-PRO Device Usability During the Translation Process: A Case Study of the Exact in 7 CountriesEremenco, S. / Murray, L. et al. | 2014
- A601
-
Health-Related Quality of Life Among Tuberculosis Patients in Pakistan: A Cross Sectional Study Using WHOQOL-BREFIqbal, M. S. / Iqbal, M. W. / Bahari, M. B. / Iqbal, M. Z. et al. | 2014
- A602
-
Patterns of Asthma Treatment Utilization in Newly Diagnosed Elderly Patients are Inconsistent With Asthma Management GuidelinesAli, A. K. et al. | 2014
- A603
-
How Much the Appropriate Tobacco Price Would Be?: A Discrete Choice Experiment of General Public in JapanIgarashi, A. / Goto, R. et al. | 2014
- A604
-
Results of A Decubitus Prevention and Wound Care ProjectDozsa, C. / Borcsek, B. et al. | 2014
- A605
-
Economic Impact of Visual Impairment: A Pilot Study in SingaporeWang, X. / Luo, N. / Lamoureux, E. / Ang, M. et al. | 2014
- A606
-
Economic Burden of Burn Injuries in the NetherlandsHop, J. M. / Wijnen, B. F. / Nieuwenhuis, M. / Dokter, J. / Middelkoop, E. / Polinder, S. / van, B. M. et al. | 2014
- A607
-
Modeled Outcomes and Overall Costs of the 13-Valent Pneumococcal Conjugate Vaccine in the Tunisian National Vaccination ProgramZigmond, J. / Pecen, L. / Tichopad, A. / Roberts, C. S. / Jomaa, I. et al. | 2014
- A608
-
Cost-Effectiveness of 13-Valent Versus 10-Valent Pneumococcal Conjugate Vaccine Use in Croatia National Vaccination ProgramTichopad, A. / Pecen, L. / Roberts, C. S. / Uglesic, L. / Tesovic, G. / Rogier, K. et al. | 2014
- A609
-
The Future Health Economic Potential of Next Generation Artificial Vision Devices for Treating Blindness in Germany: an Early Cost-Utility AssessmentSchwander, B. et al. | 2014
- A610
-
Estimating Utility Data for Patient Symptom Severity in Chronic Spontaneous UrticariaHawe, E. / Stull, D. E. / McBride, D. / Balp, M. M. et al. | 2014
- A611
-
The Burden Of Chronic Urticaria In Europe: A Systematic Literature ReviewBetoret, I. / Lambert, C. / Paravisini, A. / Tribaldos, M. / Paz, S. / Lizán, L. et al. | 2014
- A612
-
Cost-Effectiveness and Value of Information Analyses of Nutritional Support in Preventing Pressure Ulcers in High Risk Hospitalised PatientsTuffaha, H. W. / Shelley, R. / Chaboyer, W. / Gordon, L. G. / Scuffham, P. A. et al. | 2014
- A613
-
Macular Oedema Due to Retinal Vein Occlusion Methods for the Identification of Treatment Guidelines and Areas of Unmet Clinical Needs by Means of Systematic ReviewPatel, A. S. et al. | 2014
- A614
-
Comparative Effectiveness of Treatments for Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL), Using Matching Adjusted Indirect ComparisonTongbram, V. / Sengupta, N. / Gaudig, M. / Sidhu, M. / Exuzides, A. / Colby, C. / Sanden, S. V. / McGovern, A. et al. | 2014
- A615
-
Systematic Review of Relapsed or Refractory Mantle Cell Lymphoma (MCL) Clinical Trials: Implications for Decision ModelingSorensen, S. / Dorman, E. / Xu, Y. / Sallum, R. / Pan, F. / Szatkowski, A. / Gaudig, M. / Sengupta, N. et al. | 2014
- A616
-
An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)Rinciog, C. / Myrén, K. J. / Aldén, M. / Diamantopoulos, A. / LeReun, C. et al. | 2014
- A617
-
Treatment Sequencing Survival Model for Patients with Multiple Myeloma Ineligible for Stem Cell Transplantation (SCT)Heeg, B. / Van Agthoven, M. / van Beurden-Tan, C. / Liwing, J. / Mellqvist, U. H. / Plesner, T. / Logman, F. / Aschan, J. / Einsele, H. / Treur, M. et al. | 2014
- A618
-
The Importance of Long-Term Surveillance of Stage IB Melanomas: Unexpectedly Low Survival Subsequent to RecurrenceLeeneman, B. / Franken, M. G. / Blommestein, H. M. / van Gils, C. W. / van der Meijde, E. / Wouters, M. W. / Plaisier, P. W. / Kruit, W. H. / van Ruth, S. / ten Tije, A. J. et al. | 2014
- A619
-
A Validated Prediction Model and Nomogram for Risk of Recurrence in Early Breast Cancer PatientsWitteveen, A. / Vliegen, I. M. / Siesling, S. / IJzerman, M. J. et al. | 2014
- A620
-
Simulation Model of Ibrutinib for Chronic Lymphocytic Leukemia (CLL) With Prior TreatmentPan, F. / Peng, S. / Sorensen, S. / Dorman, E. / Sun, S. / Gaudig, M. / Sengupta, N. et al. | 2014
- A621
-
Budget Impact Analysis of CYP2C19 Genotyping to Target Voriconazole Prophylaxis During Induction-Consolidation Therapy in Acute Myeloid Leukemia (AML) in The United StatesMason, N. T. / Bell, G. C. / McLeod, H. L. et al. | 2014
- A622
-
Real-World Costs of Laboratory Tests for Non-Small Cell Lung Cancervan der Linden, N. / Smit, E. F. / Uyl-De Groot, C. A. et al. | 2014
- A623
-
Cost-Effectiveness and Budget-Impact Analysis of Braf Inhibitors in Patients With Metastatic Malignant Melanoma (MMM) in SloveniaHren, R. et al. | 2014
- A624
-
Costed Treatment Pathways of Diffuse Large B Cell Lymphoma in a UK Population-Based Cohort: A Patient Level Simulation ModelWang, H. I. / Smith, A. / Roman, E. / Crouch, S. / Jack, A. / Patmore, R. et al. | 2014
- A625
-
Resource Use and Health Care Costs of Cervical Lesions and Cervical Cancer in SlovakiaOndrusova, M. / Psenkova, M. / Mlyncek, M. / Masak, L. / Hlavinkova, L. / Trnovec, P. et al. | 2014
- A626
-
The Burden of Non-Small Cells Lung Cancer (NSCLC) in First Line (1L) Treatment: Patterns of Care and Cost of IllnessPiedade, A. / Goes, L. / Castro, A. P. / Alves, A. F. / Minowa, E. et al. | 2014
- A627
-
Health Care Costs and Utilization of U. S. Veteran Patients Diagnosed with Pancreatic CancerXie, L. / Kariburyo, M. F. / Wang, Y. / Baser, O. et al. | 2014
- A628
-
The Cost of NSCLC Treatment in Three Countries: France, Germany and UKMcguire, A. / Martin, M. / Lenz, C. / Sollano, J. et al. | 2014
- A629
-
A Guideline-Based Estimate of Health Care Resource Use and Cost of Metastatic Unresectable OsteosarcomaCornelio, N. / Burudpakdee, C. et al. | 2014
- A630
-
Economic Consequences of the Adaption of the 21 Gene Reverse Transcriptase-Polymerase Chain Reaction RT-PCR Assay from The Greek Third Payer PerspectiveKikilias, N. / Siskou, O. / Kaitelidou, D. / Galanis, P. / Tsoulos, N. / Vafeiadis, J. / Liaropoulos, L. et al. | 2014
- A631
-
The Potential of (TARGETED) MR Colonography as a Screening Tool for Colorectal Cancer: A Cost-Effectiveness AnalysisGreuter, M. J. / Demirel, E. / Berkhof, J. / Fijneman, R. J. / Stoker, J. / Meijer, G. A. / Coupé, V. M. et al. | 2014
- A632
-
Cost-Utility Analysis of Pazopanib Verse Sunitinib as First-Line Treatment of Metastatic Renal Cell Carcinoma (MRCC) iN SpainEspinosa, J. / González-Larriba, J. L. / Maroto, P. / Méndez-Vidal, M. J. / Díaz-Cerezo, S. et al. | 2014
- A633
-
Cost-Effectiveness of Vismodegib Verse Standard of Care Therapy in the Treatment of Locally-Advanced or Symptomatic Metastatic Basal Cell Carcinoma in Hungary – A Global Cost-Effectiveness Model AdaptationMikudina, B. / Péter, T. / Nagy, B. / Horváth, K. et al. | 2014
- A634
-
Cost-Effectiveness Analysis of Bevacizumab- Paclitaxel-Carboplatin (PC) Versus PC in First-Line Therapy of Advanced Non-Small Cell Lung Cancer from Patients' Perspective in VietnamTran, T. T. / Nguyen, T. T. et al. | 2014
- A635
-
A Cost-Effectiveness Analysis of EGFR-TK Mutation Status-Guided 1st- and 2nd-Line Treatment of Stage III/IV Non-Small Cell Lung Cancer in the UKPatel, K. / Montouchet, C. / Cheynel, J. / Ruff, L. et al. | 2014
- A636
-
Cost-Effectiveness of Radical Prostatectomy, Radiation Therapy and Active Surveillance for the Treatment of Localized Prostate Cancer – A Claims Data AnalysisBrandes, A. / Koerber, F. / Schwarzkopf, L. / Hunger, M. / Waidelich, R. / Rogowski, W. et al. | 2014
- A637
-
Will Governments be Able to Afford a Cancer Cure Under Current Health Economic Evaluation Methods?Jamali, E. / Focsa, S. et al. | 2014
- A638
-
Pharmacoeconomic Analysis of Axitinib as Second-Line Treatment for Metastatic Renal Cell CarcinomaKulikov, A. / Komarov, I. / Zinchuk, I. et al. | 2014
- A639
-
Economic Evaluation of Axitinib for Second Line Treatment in Adult Patients with Advanced Renal Cell Carcinoma – the Portuguese CaseMiguel, L. S. / Luz, R. et al. | 2014
- A640
-
Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous for the Treatment of Patients With HER2+ Early Breast Cancer And Metastatic Breast Cancer in GreeceMylonas, C. / Kourlaba, G. / Fountzilas, G. / Skroumpelos, A. / Maniadakis, N. et al. | 2014
- A641
-
Model-Based Cost–Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHSSnowsill, T. / Huxley, N. / Hoyle, M. / Crathorne, L. / Haasova, M. / Briscoe, S. / Coelho, H. / Medina-Lara, A. / Mujica, M. R. / Napier, M. et al. | 2014
- A642
-
Cost-Effectiveness of Ipilimumab in Previously Untreated Patients for Advanced Melanoma in SwedenBarzey, V. / Asukai, Y. / Gueron, B. / Holmberg, C. / Kotapati, S. et al. | 2014
- A643
-
Cost-Effectiveness Analysis of Testing for Brca Mutations in Women Diagnosed with Ovarian Cancer and their Female First-Degree Relatives: A Uk Health Service PerspectiveDyer, M. / Vereecken, W. / Worrall, J. / George, A. / Rahman, N. et al. | 2014
- A644
-
Impact on Hospitalization Derived from the Use of Denosumab for the Prevention of Skeletal-Related Events in Patients with Bone Metastases Secondary to Breast Cancer in GermanyDiel, I. / Ikenberg, R. / Cristino, J. / Gatta, F. / Qian, Y. / Arellano, J. et al. | 2014
- A645
-
Health-State Utility Values in Breast And Prostate Cancer Measured using the EQ-5D: A Systematic Review of the LiteratureHughes, R. / Mitchell, C. R. / Bishop, R. S. / Fotheringham, I. et al. | 2014
- A646
-
Patient Satisfaction Regarding their Treatment and Disease Decisions in Infra-Centimetric Breast CancerDalenc, F. / Pau, D. / Chauvet, M. P. / Belkacemi, Y. et al. | 2014
- A647
-
Health Related Quality of Life and Patient Satisfaction in Colorectal Cancer Patients Treated Through Radical Surgery in Curative Intent in a Colo-Proctology Clinical DepartmentBalderas-Peña, L. M. / Sat-Muñoz, D. / Palomares-Chacon, U. R. / Flores-Larios, E. A. / Ramírez-Conchas, R. E. / Salcedo-Rocha, A. L. / García de Alba-García, J. et al. | 2014
- A648
-
What Matters to Patients and their Caregivers: Using Social Media and Patient Forums to Obtain Valuable Information from a Patient and Carer PerspectiveChalkiadaki, C. / Martin, A. et al. | 2014
- A649
-
Patient-Reported Outcomes Assessed Using the Breast-Q Instrument in Women Undergoing Breast Reconstruction Post-Mastectomy: A Systematic Literature ReviewLee, L. J. / Milburn, C. / Macarios, D. et al. | 2014
- A650
-
Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC)Ivanescu, C. / Phung, D. / Loriot, Y. / Saad, F. / Mansbach, H. / Beer, T. M. / Tombal, B. / Holmstrom, S. et al. | 2014
- A651
-
Evidence-Based Medicine as a Driver of Improving Colorectal Cancer Screening in UkraineRubtsova, I. / Melnyk, Y. et al. | 2014
- A652
-
5-Year Survival is not an Appropriate Indicator for Cancer Control in the Population: Revisiting the Issue Based on UK DataWen, Y. / Li, S. Q. / Pan, X. F. / Wang, Y. Y. / Luo, H. J. / Zhao, Z. M. / Zhao, Y. / Chang, H. / Xue, Q. P. / Yang, C. X. et al. | 2014
- A653
-
Process Mapping to Capture Breast Cancer Patients' Journey in Greek Public Oncological HospitalsKaitelidou, D. / Kalogeropoulou, M. / Katostaras, T. / Minogiannis, P. / Skitsou, A. / Siskou, O. / Liaropoulos, L. et al. | 2014
- A654
-
Impact of Introducing Costs/Qaly Threshold on Access to Oncology Medicines in SlovakiaPsenkova, M. / Mackovicova, S. / Tomek, D. et al. | 2014
- A655
-
Treatment Patterns and Costs Of Neoadjuvant Systemic Therapies (NAT) For Early Breast Cancer (EBC): A Retrospective Claims AnalysisChen, Y. J. / Santos, E. / Schabert, V. / Antao, V. P. / De, A. P. / Portera, C. C. / Wang, Y. / Kamath, T. et al. | 2014
- A656
-
What are the Health Care Resource Utilization and Medical Cost of Untreated Patients with Neuroendocrine Tumors in the United States?Chuang, C. C. / Dinet, J. / Bhurke, S. / Chen, S. Y. / Gabriel, S. et al. | 2014
- A657
-
Health Care Resource Utilization (HCRU) In Hospitalized Febrile Neutropenia (FN) Patients Treated With Chemotherapy for Solid Tumors (ST) And Hematological Malignancies (HM) In Bulgaria (BG), Czech Republic (CZ) And Slovakia (SK) As Observed In Clinical PracticeMihaylov, G. / Mihaylova, Z. / Drgona, L. / Cipkova, A. / Novak, J. / Petrova, R. et al. | 2014
- A658
-
Reimbursement of Targeted Cancer Therapies Within Three Different European Health Care SystemsMihajlović, J. / Dolk, C. / Postma, M. J. et al. | 2014
- A659
-
Comparing Access to Drugs Through the CDF and by Nice – The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label UsageMacaulay, R. et al. | 2014
- A660
-
Nice Restrictiveness Compared to the Market Authorization In Oncology And Non-Oncology ReviewsJaksa, A. / Westbrook, L. / Rubinstein, E. / Daniel, K. / Ho, Y. S. et al. | 2014
- A661
-
Applicability Of Eunethta Relative Effectiveness Assessment of Pazopanib For National AssessmentsKleijnen, S. / Leufkens, H. G. / Boer, A. / Goettsch, W. / Fathallah, M. et al. | 2014
- A662
-
Towards a Framework for Analysing Sustainability of Economic Value: The Case of a Short Stay Programme for Breast Cancer Surgery Care Five Years After ImplementationAment, S. / Gillissen, F. / Maessen, J. / van der Weijden, T. / von Meyenfeldt, M. / Dirksen, C. D. et al. | 2014
- A663
-
Prescribing Pattern of Anti-Emetics for Prevention of Chemotherapy Induced Nausea & Vomiting—An Observation of Clinical Practice Versus Standard GuidelinesPatel, H. / Parthasarathi, G. / Ramesh, M. et al. | 2014
- A664
-
Retrospective Public Health Impact of a Quadrivalent Influenza Vaccine in the United States Over the Period 2000-2014Crépey, P. / de Boer, P. / Postma, M. J. / Pitman, R. J. et al. | 2014
- A665
-
Ten Years Outcomes in a Cohort of Patients Started on Antiretroviral Treatment in an Urban Clinic in Sub-Saharan AfricaCastelnuovo, B. / Sempa, J. / Nyakato, P. / Musaazi, J. / Kambugu, A. / Kamya, M. / Kiragga, A. et al. | 2014
- A666
-
Meta-Regression on European Zoster IncidenceTerlinden, A. / Varghese, L. / Curran, D. et al. | 2014
- A667
-
Budget Impact Analysis of 13-Valent Pneumococcal Vaccine in Adult Population with Comorbidities or Immunocompromised from the Public Payer Perspective In BrazilFerreira, C. N. / Manfrin, D. F. / Rufino, C. S. / Gea, Y. / Haas, L. C. / Fernandes, R. A. et al. | 2014
- A668
-
Economic Evaluation of Vaccination Against Hav in High Risk PopulationDimitrova, M. / Petrova, G. et al. | 2014
- A669
-
Potential Risk-Sharing Agreements for VaccinesTerlinden, A. / Ethgen, O. / Demarteau, N. / Curran, D. et al. | 2014
- A670
-
Epidemiology and Costs of Varicella and Herpes Zoster in GermanyDamm, O. / Horn, J. / Schmidt, T. / Neubauer, S. / Zeidler, J. / Mikolajczyk, R. / Greiner, W. / Ultsch, B. et al. | 2014
- A671
-
Cost of Influenza and Acute Respiratory Infections Treatment in UkraineZalis'ka, O. / Leleka, M. / Kosyachenko, K. / Zaliskyy, O. et al. | 2014
- A672
-
An Observational Propensity Score-Matched Study to Evaluate Cost-Effectiveness of a Real-Time Pcr-Based Assay in Patients with Suspected SepsiskZaniolo, O. / Povero, M. / Pradelli, L. / Pizzorno, B. / Mancini, N. et al. | 2014
- A673
-
Cost-Effectiveness of Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) in SwedenVan Engen, A. / Lie, X. / Norén, T. / Nordling, S. / Nørgaard, K. et al. | 2014
- A674
-
Costs and Effectiveness of Combination Therapy with Bedaquiline and other Anti-Tuberculosis Drugs in Patients with Multi- and Extensively Drug-Resistant Tuberculosis in GermanyWolfson, L. / Wirth, D. / Jibbert, J. / Diel, R. / Rutz, S. et al. | 2014
- A675
-
How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?Höhne, J. M. / Demarteau, N. / Saka, . / Standaert, B. / Kleintjens, J. et al. | 2014
- A676
-
Cost-Effectiveness of Human Papillomavirus Vaccination Programmes Parallel to Current Routine Vaccination of Young Teenage GirlsWestra, T. A. / Postma, M. J. et al. | 2014
- A677
-
Switching from an EFV-Based STR to a RPV-Based STR is Effective, Safe and Improves HIV Patients Health StatusDi Matteo, S. / Bruno, G. M. / Astuti, N. / Di Filippo, E. / Valenti, D. / Colombo, G. L. / Maggiolo, F. et al. | 2014
- A678
-
Cost-Effectiveness of Dolutegravir, a New Generation Integrase Inhibitor, in Hiv-1 Treatment Experienced Patients in FranceDespiégel, N. / Marcellin, A. G. / Aubin, C. / Espinas, C. / Laurisse, A. / Pialoux, G. et al. | 2014
- A679
-
Health Economic Model for Novel in Vitro Diagnostic Kit for Infective EndocarditisBaumgartner, C. J. / Hugi, C. / Matt, T. et al. | 2014
- A680
-
Predicting the Impact of Adverse Events and Treatment Duration on Medical Resource Utilisation Related Costs in Hepatitis C Genotype 1 Treatment-Naïve Patients Receiving Antiviral TherapyAkpo, H. / Cerri, K. / Sbarigia, U. / Kleintjens, J. et al. | 2014
- A681
-
Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHALalanne, C. / Duracinsky, M. / Marcellin, F. / Lert, F. / Chassany, O. / Carrieri, P. M. / Dray-Spira, R. / Spire, B. et al. | 2014
- A682
-
Prescription Practices for Uncomplicated Malaria at two Public Health Facilities in Nigeria; A Descriptive, Comparative StudyEzenduka, C. C. / Okonta, J. / Esimone, C. O. et al. | 2014
- A683
-
Coverage or Efficacy: Which Factor is the Most Influential for Reducing Varicella with Routine Childhood Vaccination in Italy?Sauboin, C. / Holl, K. / Amodio, E. / Bonanni, P. / Gabutti, G. / Vitale, F. et al. | 2014
- A684
-
Evaluation of the Effectiveness of Implementing an Antimicrobial Stewardship Program in a Medical Center in TaiwanHuang, L. / Kuo, C. / Lin, Y. / Chen, Y. / Wong, Y. et al. | 2014
- A685
-
The Study on the Prescribing Pattern of Acinetobacter Infection in a Tertiary Care HospitalVilakkathala, R. / Sudhapalli, V. / Kanad, D. / Mallayasamy, S. et al. | 2014
- A687
-
Research Presentations Financial Disclosure Statements ISPOR 17th Annual European Congress Research Abstracts| 2014
- A719
-
Impact of Glp-1RA on Heart Rate, Blood Pressure and Hypertension Among Type 2 Diabetes: A Systematic Review and Network Meta-AnalysisSun, F. / Wu, S. / Chai, S. / Yang, Z. / Yu, K. / Zhan, S. et al. | 2014
- A720
-
Example of Analysis Utilizing Real World Data: Medical Cost Reduction of Combination DrugsIwasaki, K. / Kogo, N. / Dei, M. et al. | 2014
- A721
-
Qualitative Assessment of the Quality of Pharmaceutical Care Services in the Province of Khyber Pakhtunkhwa, Pakistan: Hospital Pharmacists' ViewsMurtaza, G. / Kousar, R. / Azhar, S. / Khan, S. et al. | 2014
- A722
-
Comparison of Oral Versus Intravenous Nsaids for the Treatment of Patent Ductus Arteriosus in Preterm and/or Low Birth Weigh Infants: A Systematic Review and Meta-AnalysisChaiyapak, R. et al. | 2014
- A723
-
Anticipated Price Disclosure: Impact on Funding Decisions in AustraliaHarrison, J. / Cook, G. / Kim, H. et al. | 2014
- A724
-
Impact of Maternal Education on Child Immunization Propensity in ChinaDing, Y. / Hay, J. et al. | 2014
- A725
-
Resource Utilization Pattern And Cost Of Tuberculosis Treatment In Penang, MalaysiaAtif, M. / Sulaiman, S. A. / Shafie, A. A. / Asif, M. et al. | 2014
- A726
-
Acute Respiratory Distress Syndrome: Treatment Pattern and Outcome AnalysisPrabhu, V. A. / Awasthi, S. / Shanavas, R. / Kunhikatta, V. / Thunga, G. / Acharya, R. et al. | 2014
- A727
-
Health Economics Methodologies Involving Parkinson's Disease Treatment in ChinaLow, W. / Azmi, S. / Yee, S. L. / Milea, D. et al. | 2014
- A728
-
Health Care Databases Applied to Antidepressants Use in Asia-PacificMilea, D. / Reginald, P. / Saragoussi, D. / Kalita, P. / Verpillat, P. / Azmi, S. et al. | 2014
- A729
-
Comparing the Event Prediction Capability of the Ukpds68 and Hong Kong Diabetes Risk Equations within A Type 2 Diabetes Simulation ModelMcEwan, P. / Ward, T. / Bennett, H. / Bergenheim, K. et al. | 2014
- A730
-
Construct Validity of SF-6D Health State Utility Values in an Employed PopulationBaxter, S. / Sanderson, K. / Venn, A. / Otahal, P. / Palmer, A. J. et al. | 2014
- A731
-
Sqaros – Standardized Questionnaire to Assess the Reliability of Observational StudiesKaczynski, L. / Solnica, B. et al. | 2014
- A732
-
WX-III-287-19 A Possible Thromboxane Antagonist in Bovine Coronary ArteriesShah, A. J. / Gauthier, K. M. / Imig, J. D. / Falck, J. R. / Campbell, W. B. et al. | 2014
- A733
-
A Systematic Literature Review on Risk Factors for Cervical Cancer in Chinese PopulationJiang, Y. / Hu, S. / Hernandez Donoso, L. / Li, X. / Zheng, M. / Zhao, F. et al. | 2014
- A734
-
Cost-Effectiveness Analysis of the Original Drug ArglabinKalyieva, S. / Minakova, N. / Yukhnevich-Nassonova, Y. et al. | 2014
- A735
-
Cost-Effectiveness Of Para-Aortic Lymphadenectomy Before Chemoradiotherapy in Locally Advanced Cervical CancerLee, J. / Kim, J. et al. | 2014
- A736
-
COST-EFFECTIVENESS OF POST-THERAPY PET AND TELEPHONE INTERVIEW IN THE CLINICAL FOLLOW-UP OF PATIENTS TREATED WITH LOCALLY ADVANCED CERVICAL CANCERHou, C. / Siva, S. / Haas, M. / Viney, R. et al. | 2014
- A737
-
Attitude Assessment of the Human Papilloma Virus (Hpv) in HungaryVajda, R. / Pakai, A. / Boncz, I. / Ágoston, I. / Endrei, D. / Horváthné Kívés, Z. et al. | 2014
- A738
-
Health-Related Quality of Life In Patients With Cervical Cancer in IndonesiaEndarti, D. / Riewpaiboon, A. / Thavorncharoensap, M. et al. | 2014
- A739
-
In Vitro Drug Release and Ex Vivo Permeation Study of Prepared Mouth Dissolving Tablets of Fluconazole Through Porcine Buccal MucosaChakraborty, T. / Saini, V. et al. | 2014
- A740
-
Incretin Therapy and Risk of Pancreatitis in Type 2 Diabetes Mellitus: Systematic Review of Randomized and Non-Randomized StudiesLi, L. / Shen, J. / Bala, M. / Busse, J. / Ebrahim, S. / Vandvik, P. / Rios, L. / Malaga, G. / Wong, E. / Sohani, Z. et al. | 2014
- A741
-
Design & Methods For Study Of Prevalence, Risk Factors And Economic Burden Of Insulin Injection-Related Lipohypertrophy In ChinaTao, L. / Chandran, A. / Hirsch, L. / Wei, Z. / Wang, D. / Ji, L. / Sun, Z. / Qin, G. / LI, Q. et al. | 2014
- A742
-
Hydroxyethyl Starch And Hospitalized Mortality In Icu Patients With Diabetes: Database Study From A Chinese Tertiary HospitalLi, S. / Yu, C. / Li, Y. / Zhang, R. / Ma, Y. / Hou, Q. / Li, Q. / Zheng, T. / Wang, M. / Su, N. et al. | 2014
- A743
-
Medical Expenditure For People With Diabetes In Urban Employee Basic Medical Insurance For Hebei Provincial InstitutesLiu, S. / Zhang, P. / Ma, S. / Yu, L. / Liu, Y. / Du, B. et al. | 2014
- A744
-
Evaluating The Long-Term Cost-Effectiveness Of Liraglutide 1.2 Mg And Exenatide In Patients With Type 2 Diabetes MellitusShi, L. / Han, S. / LIU, F. et al. | 2014
- A745
-
Cost Utility Of Diabetes Drugs Using Hba1c As A Direct Predictor For Quality Of Life, Diabetes Complications And MortalityKim, H. / Gurrin, L. / Magliano, D. / Liew, D. et al. | 2014
- A746
-
Does diabetes have an impact on health-state utility? A study of asians in singaporeWang, P. / Tai, E. / Thumboo, J. / Hubertus, V. / Luo, N. et al. | 2014
- A747
-
The Impact Of Drug Price Control Policy For Diabetes Medication: A Longitudinal Analysis In TaiwanLai, C. / Lai, M. et al. | 2014
- A748
-
ESTIMATED ECONOMIC BURDEN OF INSULIN INJECTION-RELATED LIPOHYPERTROPHY IN CHINESE PATIENTS WITH DIABETESTao, L. / Zhang, X. / Strauss, K. / Hirsch, L. / Chandran, A. et al. | 2014
- A749
-
Economic Evaluation of Viral Load Test (VLT) in Response Guided Treatment (RGT) for Chronic Hepatitis C (CHC)Mao, W. / Chen, W. / Wei, L. et al. | 2014
- A750
-
Efficacy of Atropine Alone and with Glycopyrrolate Combination in Organophosphate PoisoningBhandarkar, A. A. et al. | 2014
- A751
-
An Update of Cost-Effectiveness of Rotavirus Vaccination in Indonesia: Taking a Birth-Dose Vaccination Strategy into AccountSuwantika, A. A. / Setiawan, D. / Atthobari, J. / Postma, M. J. et al. | 2014
- A752
-
Assessment of Utilities in Japan: Data Availability and MethodologyChen, X. / Kim, H. R. / Crawford, B. et al. | 2014
- A753
-
Assessing Factors Associated with Youth Substance Abuse in the us Using a Structural Equation ModelZhao, Y. / Gu, N. Y. et al. | 2014
- A754
-
Construct a Cpoe Decision Supporting and Monitoring System to Decrease Pims Used in Hospitalized Elderly PatientsChu, L. L. / Su, H. C. / Wang, H. Y. et al. | 2014
- A755
-
Comparative Study On Health Related Quality Of Life Of Farmers And WorkersLiu, X. / Duan, S. / Wu, Y. / Ye, C. / Wang, J. / Dong, H. et al. | 2014
- A756
-
Nursing Diagnosis and Some Physiological Signs and Their Changes During the Arterial HypertensionAzjargal, B. / Zevgee, T. / Bat-Sereedene, B. / Naranchimeg, S. / Oyunaa, C. / Odongua, N. et al. | 2014
- A757
-
Effectiveness of Catheter-Based Renal Denervation for Treatment Resistant Hypertension – Results of a Systematic Review and Meta-AnalysisMcBride, M. / Krum, H. / Schlaich, M. / Whitbourn, R. / Walton, T. / Tilden, D. / Gillespie, J. et al. | 2014
- A758
-
Use of Beta Blocking Agents in Serbia in the Period from 2008 to 2012 YearMilijasevic, B. / Tomic, N. / Milijasevic, D. / Horvat, O. / Stilinovic, N. / Mikov, M. et al. | 2014
- A759
-
Medical Costs of Cardiovascular Diseases in TaiwanTang, C. H. / Chuang, P. Y. / Chen, C. A. / Fang, Y. C. et al. | 2014
- A760
-
Cost-Effectiveness Analysis of Fondaparinux Versus Enoxaparin in Non-St Elevation Acute Coronary Syndrome in ThailandPermsuwan, U. / Chaiyakunapruk, N. / Nathisuwan, S. / Sukonthasarn, A. et al. | 2014
- A761
-
A Cost-Utility Analysis of Calcium Channel Blockers (Ccbs) Compared with Angiotensin II Receptor Blockers (Arbs) In Preventing Stroke And Myocardial Infarction Among Hypertension Patients In The TaiwanFang, C. H. / Lin, K. Y. / Huang, Y. C. / Liu, L. et al. | 2014
- A762
-
Setting up the Right Scenarios for Cost-Effectiveness Analysis: An Example with Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients in ChinaWan, Y. / Lu, Z. G. / Chen, F. / Chen, J. et al. | 2014
- A763
-
Effect of Pharmaceutical Care on the Quality of Life in the Patients of Coronary Artery DiseaseTumkur, A. / Muragundi, P. M. / Shetty, R. K. / Nagappa, A. N. et al. | 2014
- A764
-
Lipid Control After Percutaneous Coronary Intervention (PCI) in ChinaWei, M. / Sun, Y. / Liu, G. / Hei, Y. / Zhao, Z. et al. | 2014
- A765
-
Minimum Clinically Important Difference in the Global Assessment Functioning in Patients with SchizophreniaAmri, I. / Millier, A. / Toumi, M. et al. | 2014
- A766
-
Functional Impairment and Cognitive Dysfunction in Depressed Patients in South-Korea: Results of Perform-KKim, J. M. / Chalem, Y. / Di Nicola, S. / Hong, J. P. / Won, S. H. / Milea, D. et al. | 2014
- A767
-
Economic Burden of Schizophrenia in China: Based on Medical Insurance Database from Guangzhou CityHuang, Y. / Liu, G. / Liu, Y. H. / Zhang, H. et al. | 2014
- A768
-
Cost and Resource Use of Managing Major Depressive Disorder (MDD) in ChinaLow, W. / Azmi, S. / Yee, S. L. / Abdat, A. / Yang, Y. / Milea, D. et al. | 2014
- A769
-
Examining Opioid-Dependent Chronic Pain Patients Experiences On Buprenorphine Maintenance Therapy In The Texas Workers Compensation System: Pilot Study - Part 2Nwokeji, E. D. / Rascati, K. L. / Nemeth, W. C. / Jordan, K. D. / Novak, S. et al. | 2014
- A770
-
Public Beliefs and Attitudes about Schizophrenia, Major Depression and Psychotropic Medication in TunisiaRefaï, T. / Millier, A. / Rémuzat, C. / Toumi, M. et al. | 2014
- A771
-
The Effects of Gallium Chloride on Apoptosis Osteoporosis Model of Rats Caused by Tretinoin AcidChen, Q. / Liu, D. / Xiong, Y. M. / Wang, Z. L. et al. | 2014
- A772
-
The Costs of Major and Minor Cycling Accidents in Tasmania, AustraliaPalmer, A. J. / Si, L. / Gordon, J. et al. | 2014
- A773
-
Cost-Effectiveness of denosumab vs. Brand or generic zoledronic acid in patients with prostate cancer in kazakhstanBektur, C. / Nurgozhin, T. et al. | 2014
- A774
-
Relationship Between Hip Muscle Strength and Kinematics of the Knee JointMunkh-Erdene, B. / Oyunaa, C. / Tserendagva, D. et al. | 2014
- A775
-
Stakeholder Evidence Requirements and Price Expectations for Biosimilars in Three Asian MarketsAkpinar, P. / Saraf, S. / Severi Bruni, D. / Li, X. / Liu, C. / Sherwin, G. et al. | 2014
- A776
-
COUGH AS A KEY SYMPTOM IN ASTHMA, ALLERGIC RHINITIS, COPD AND RHINOSINUSITIS AND ITS IMPACT IN ASIAWang, D. Y. / Ghoshal, A. G. / Razak Bin Abdul, M. A. / Lin, H. C. / Thanaviratananich, S. / Bagga, S. / Faruqi, R. / Brnabic, A. J. / Dehle, F. C. / Cho, S. H. et al. | 2014
- A777
-
Incidence-Based Cost of Asthma in VietnamNguyen, N. B. / Nguyen, T. T. et al. | 2014
- A778
-
Cost-Benefit Analysis of Bacterial Lysates for Chronic Obstructive Pulmonary Disease in ChinaMa, J. / Liu, G. / Yao, Y. / Xu, F. / Lv, N. et al. | 2014
- A779
-
Health Status in Adult Patients with Copd in KoreaKim, E. S. / Lee, B. J. / Lee, G. W. / Jung, A. / Hwang, H. S. et al. | 2014
- A780
-
Smoking Cessation Treatment Patterns and Characteristics of Patients with Copd Who are Attempting to Quit in Urban ChinaGoren, A. / Feng, Y. / Gupta, S. / Chen, C. I. et al. | 2014
- A781
-
The Economic Burden and their Predictors in Preschool Children with Dental Caries in Urban BeijingZhang, Y. / Yang, L. et al. | 2014
- A782
-
Cost Utility Analysis of Ustekinumab for the Treatment of Moderate to Severe Chronic Plaque Psoriasis in ThailandTangwongsiri, D. / Leartsakulpanitch, J. et al. | 2014
- A783
-
Clinical Efficacy of the Polyherbal Ayurvedic Medicine in The Management of OverweightSasikumar, U. H. / Acharya, S. / Reddy, K. / Nagappa, A. N. et al. | 2014
- A784
-
Prevalence of Neuropathic Pain in Korean Patients Scheduled for Lumbar Spine Surgery and their Health Related Quality of Life: Nationwide, Multicenter, Prospective, Cross-Sectional, Observational StudyCho, Y. E. / Kim, K. H. / Kim, H. J. et al. | 2014
- A785
-
The Performance- Volume Limit Decreased the DRG Based Acute Care Hospital Financing in hungaryEndrei, D. / Decsi, T. / Gazsó, T. / Ágoston, I. / Csákvári, T. / Kovács, G. / Boncz, I. et al. | 2014
- A786
-
The Impact on Drug Price and Patiet Selection of National Essential Drug System: Evidence From Inpatient Records from Insurance Reimbursement DataDu, N. / Xu, J. et al. | 2014
- A787
-
How do Organizational Arrangements of the Pharmaceutical Supply System Affect Availability to Essential Medicines in Rural China?Zuo, G. et al. | 2014
- A788
-
Use of Medications in the Event of Job LossLiu, X. et al. | 2014
- A789
-
Drug Access Is Improved By The Essential Drug System And “Low-Priced Drug” Policy In ChinaLiu, M. / Huang, L. / Zhao, D. / Xu, L. et al. | 2014
- A790
-
The Impact of the Income Per Capita in Chinese Family on Medical ExpenditureHe, X. et al. | 2014
- A791
-
Evaluating the Impact of Drug Dispensing Systems on the Safety and Efficacy in a Singapore Outpatient PharmacyOng, Y. S. / Chen, L. L. / Wong, J. A. / Gunawan, Y. / Goh, W. J. / Tan, M. C. / Lee, S. B. et al. | 2014
- A792
-
Investigating the Knowledge of Pharmacists about Cosmetics Products in Pharmacies of Tehran (IRAN)Ghiasi, G. / Hashemian, F. / Kebriaeezadeh, A. / Ghiasi, S. / Sheikhlar, A. et al. | 2014
- A793
-
Review of Taiwan Nhia's Two-Stage New Drugs Listing and Reimbursement Assessments (2013-Feb. 2014)Wang, J. C. / Gau, C. S. et al. | 2014
- A794
-
Regulatory Approval to Patient Access, an Evaluation of EU5 and us National Timing DifferencesMycka, J. / Dellamano, R. / Lobb, W. / Dalal, N. / Pereira, E. / Dellamano, L. / Sagaydachnaya, O. et al. | 2014
- A795
-
What are the Key Driving Factors Behind RSA Decisions In Australia?Nash, P. / Martin de Bustamante, M. A. et al. | 2014
- A796
-
Fostering Patient Safety Culture in Hospital to Improve Health Service: Hospital Survey on Patient Safety CultureJia, P. / Zhang, L. / Mao, X. / Zhang, M. et al. | 2014
- A797
-
Do HTA Processes Correlate With Reimbursement Recommendations?Allen, N. / Lipska, I. / Liberti, L. / Salek, M. S. et al. | 2014
- A798
-
What is the Status of Health Related Quality of Life Among Medical Representatives in India?Muragundi, P. M. / Kotlo, A. / Maram, A. / Krovvidi, S. A. / Srikanth, M. V. / Udupa, N. / Naik, A. N. et al. | 2014
- A799
-
An Analysis of Quality of Care in the Respiratory Care Center Based on Services Provided by Physicians with Different Responsibilities and SpecialtiesChung, Y. C. / Cheng, K. C. / Tseng, K. L. / Shieh, J. M. / Hsing, S. C. et al. | 2014
- A800
-
Evidences and Criteria Related to the Hospital Service Quality and SafetyBatmanduul, E. / Oyunzul, A. / Enkhbolor, G. / Odongua, N. et al. | 2014
- A801
-
Model Based Medicine: A Next Frontier in Health CareDinh, T. et al. | 2014
- A802
-
Impact of Cigarette and Alcohol Use on Adverse Drug Reactions of Haart Therapy Among HIV/AIDS PatientsKhan, A. H. / Syed Sulaiman, S. A. / Khan, K. / Soo, C. T. / Akhtar, A. et al. | 2014
- A803
-
Burden of Varicella in Asia-Pacific Countries: A Systematic Review and Critical AnalysisYang, H. K. / Huang, M. Y. et al. | 2014
- A804
-
Clinical Outcomes and Hospital Costs Associated with Empirical Treatment of Hospital-Acquired Pneumonia with Vancomycin or Linezolid in a Chinese Tertiary Care Hospital: A Retrospective Cohort StudyYang, Y. / Song, Y. / Chen, W. / Liu, W. / Wang, K. / Li, X. / Papadimitropoulos, M. / Montgomery, W. et al. | 2014
- A805
-
Cost-Effectiveness of Infant Vaccination with 13-Valent Versus 10-Valent Pneumococcal Conjuvate Vaccine in KoreaLee, J. Y. / Park, D. J. et al. | 2014
- A806
-
Cost-Effectiveness of Hepatitis a Vaccination in IndonesiaSuwantika, A. A. / Beutels, P. / Postma, M. J. et al. | 2014
- A807
-
Assessment of Quality of Life in Human Immunodefieciency Virus Positive Patients with Adverse Reactions to Antiretroviral Therapy in Tertiary Care HospitalAluri, R. K. et al. | 2014
- A808
-
Ivacaftor for Patients with Cystic Fibrosis: Clinical Efficacy and Cost-EffectivenessKostyuk, A. / Nurgozhin, T. / Akanov, A. et al. | 2014
- A809
-
The Impact of Mutliple Sclerosis Severity on Quality of Life, Stress, Depression and Social Support NeedsColman, S. / O'Leary, B. A. / Palmer, A. J. / Simmons, R. et al. | 2014
- A810
-
Tadalafil in Benign Prostatic Hyperplasia: Protocol for the Systematic Review of Adverse EventsSingh, A. / Jha, R. K. / Kapoor, A. / Gupta, J. et al. | 2014
- A811
-
Financial Implications to Taiwan Health System from Changing the Dialysis Modality MixYang, W. C. / Hsu, C. C. / Liu, F. X. et al. | 2014
- A812
-
A Comparison of Patient-Reported and Laboratory Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian PopulationYeo, Q. M. / Wee, H. L. / Tyagi, P. / How, P. et al. | 2014
- A814
-
Research Presentations Financial Disclosure Statements ISPOR 6th Asia-Pacific Conference Abstracts| 2014
- I
-
Instructions for Authors| 2014
- i
-
Table of Contents| 2014
-
Economic Burden of Eye Disease in Diabetic Patients: Literature ReviewRiera, M. / Granell, M. / Sarycheva, A. / Roura, M. et al. | 2014
-
Cervical Human Papilloma Virus (HPV) DNA Primary Screening Test Results of the Experience of a Regional Laboratory in Central ItalyPassamonti, B. U. / Bulletti, S. / Gustinucci, D. / Martinelli, N. / D'Amico, M. R. / Spita, N. / Malaspina, M. / Carlani, A. / DI Dato, E. / Galeazzi, P. et al. | 2014
-
Treatments for EGFR Mutation-Positive (M+) NSCLC Patients – A Network Meta-Analysis (NMA) by Mutation TypePopat, S. / Lungershausen, J. / Griebsch, I. / Marten, A. / Wu, Y. L. et al. | 2014
-
Simulation Model of Ibrutinib in Treatment of Relapsed or Refractory Mantle Cell Lymphoma (MCL)Peng, S. / Sorensen, S. / Pan, F. / Dorman, E. / Sun, S. / Van Sanden, S. / Sengupta, N. / Gaudig, M. et al. | 2014
-
A Systematic Literature Review of the Economic Burden in Multiple MyelomaRizzo, M. / Xu, Y. / Panjabi, S. / Iheanacho, I. et al. | 2014
-
Economic Burden of Chemotherapy Related Toxicities in Third Line Metastatic Breast Cancer PatientsMajethia, U. / Tremblay, G. / He, Y. P. / Faria, C. / Mccutcheon, S. / Kopenhafer, L. / Forsythe, A. et al. | 2014
-
Economic Evaluation of Paclitaxel Albumin, Paclitaxel, and Docetaxel as a Second Line Treatment for Metastatic Breast CancerGharaibeh, M. / Malone, D. C. et al. | 2014
-
Estimating the Voi of Pivotal Studies Towards Predictive Biomarkers of High Dose Alkylating Chemotherapy in Triple Negative Breast CancerMiquel Cases, A. / Retèl, V. P. / van Harten, W. H. / Steuten, L. M. et al. | 2014
-
Amnog Benefit Assessment for Oncologic and Orphan Drugs in Germany – Implications for Price DiscountsTheidel, U. / Wahlers, K. / Mittendorf, T. et al. | 2014
-
Health State Utility Valuation in Radio-Iodine Refractory Differentiated Thyroid Cancer (RR-DTC)Kerr, C. / Fordham, B. / de Freitas, H. M. / Pelletier, C. L. / Lloyd, A. et al. | 2014
-
Investigating the Framing-Effects of Risk Attributes in Discrete Choice Experiments: A Pilot StudyVass, C. M. / Rigby, D. / Campbell, S. / Payne, K. et al. | 2014
-
Misuse, Abuse, and Diversion of instanyl® (Fentanyl Nasal Spray) in FranceBlin, P. / Dureau, C. / Lamarque, S. / Bernard, M. A. / Robinson, P. / Lassalle, R. / Grolleau, A. / Droz, C. / Moore, N. et al. | 2014
-
An Italian Oncology Research to Evaluate Adherence to Clinical Guidelines for Cancer Treatment: The Right ProgramSgarbi, S. / Simoni, L. / Ori, A. / Fiori, G. G. / Maiello, E. / Barni, S. et al. | 2014
-
Testing The Utility Of The Nhs's Systemic Anti-Cancer Therapy Data Set For Multi-Indication PricingMcNamara, L. / McNamara, S. et al. | 2014
-
Health Technology Assessments In Oncology: Crizotinib Case StudyThivolet, M. / Kornfeld, A. / Toumi, M. et al. | 2014
-
Results of Comparative Study of Macrolide Group Antibiotics Consumption in Ukraine, Russia and KazakhstanIakovlieva, L. / Matyashova, N. / Bondarenko, D. et al. | 2014
-
Economic Evaluation of Fidaxomicin for the Treatment of Clostridium Difficile Infections (CDI) also Known as Clostridium Difficile-Associated Diarrhoea (CDAD) in SpainCobo Reinoso, J. / Grau Cerrato, S. / Mensa Pueyo, J. / Salavert Lletí, M. / Toledo, A. / Anguita, P. / Rubio-Terrés, C. / Rubio-Rodríguez, D. et al. | 2014
-
Public Health and Economic Impact of Vaccinating Children with a Quadrivalent live Attenuated Influenza Vaccine in France Using a Dynamic Transmission ModelGerlier, L. / Weil-Olivier, C. / Carrat, F. / Lenne, X. / Lamotte, M. / Greneche, S. / Eichner, M. et al. | 2014
-
Allocating Vaccine Funds for Pneumococcal Vaccination of Infants and Older Adults: A Method for Strategic Evaluation in the NetherlandsDelgleize, E. / Standaert, B. et al. | 2014
-
The Importance of Sensitivity Analysis in Assessing Clinical and Economic Impact of National Immunization Programs: An Example of SloveniaHren, R. / Delgleize, E. et al. | 2014
-
The Pan-Genotypic Costs-Effectiveness Of Sofosbuvir in Hepatitis C VirusNovak, A. / Drenth, J. P. / de Knegt, R. J. et al. | 2014
-
The Cost-Effectiveness of Different Scenarios of Detecting of TB Among HIV-Infected People Depending on CD 4+ CountShumlyanskaya, V. et al. | 2014
-
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United StatesDe Boer, P. T. / Pitman, R. J. / Macabeo, B. / Chit, A. / Postma, M. J. / Crépey, P. et al. | 2014
-
What explains willingness to pay for avoiding morbidity risk due to malaria? Results from a global meta analysisKutluay, Y. M. / Brouwer, R. / R.S.J., T. et al. | 2014
-
Early Switch/Early Discharge Opportunities for Hospitalized Patients with Methicillin-Resistant Staphylococcus Aureus Complicated Skin And Soft Tissue Infections: Proof Of Concept in the United Arab EmiratesEl Houfi, A. / Javed, N. / Nathwani, D. / Solem, C. T. / Macahilig, C. P. / Stephens, J. M. / Raghubir, N. / Hájek, P. / Li, J. Z. / Haider, S. et al. | 2014
-
Gender-Related Behaviors in Drug Consumption In ItalyOrlando, V. / Bruzzese, D. / Putignano, D. / Guerriero, F. / Tettamanti, A. / Menditto, E. et al. | 2014
-
A Comparison of Cobb-Douglas, Translog and Additive Models of the Production Functions of Inpatient Services In Public HospitalsReyes-Santias, F. / Antelo, M. / Rodriguez-Alvarez, M. X. / Vivas-Consuelo, D. / Cadarso-Suarez, C. / Caballer-Tarazona, V. et al. | 2014
-
Value of Life and Cost of Pre-Mature Deaths With The Perspective of Productivity As Net Tax Revenue: A Comparison in France, Germany, Italy, Spain, United KingdomTuna, E. / Yenilmez, F. B. / Atikeler, K. / Kockaya, G. / Tatar, M. et al. | 2014
-
Exposure To Potential Drug-Drug Interactions in Teaching Hospital Of South Punjab, PakistanKhan, H. M. / Butt, H. / Shah, N. H. et al. | 2014
-
Cost and Quantity Characteristics of Medical Devices In SlovakiaMalovecká, I. / Minariková, D. / Lehocká, L. / Foltan, V. et al. | 2014
-
Global HTA Assessments of Ultra-Orphan Products: A Case Study Of Eculizumab (Soliris) and Iduronate-2-Sulfatase (Elaprase)Paul, A. / Morawski, J. / Spinner, D. S. / Doyle, J. J. / Faulkner, E. C. / Ransom, J. F. et al. | 2014
-
Clinical Trial Activity in Greece From 2010 To 2012: Still Missing the Opportunities?Athanasakis, K. / Boubouchairopoulou, N. / Alexiou, V. / Baroutsou, B. / Kyriopoulos, J. et al. | 2014
-
Impact of Story Books on Promoting Knowledge and Behavior of 4th Stage Elementary Students About Rational Use of Medicines in Kermanshah Provine of Iran 2008Mohammadhosseini, N. et al. | 2014
-
Trends and Key Decision Drivers For Rejecting An Orphan Drug Submission Across Five Different HTA AgenciesMardiguian, S. / Stefanidou, M. / Sheppard, F. et al. | 2014
-
Discrepancy Between National Drug Recommendations And Local Uptake in the Swedish Inpatient SectorMcGee, M. A. / Izmirlieva, M. / Ando, G. et al. | 2014
-
Disease Burden in Brazil and Health Technology Assessment: A Retrospective of Ten Years of SupportingKoury, C. D. / Elias, F. T. et al. | 2014
-
Adaptive Video Games can Assess and Enhance Cognitive HealthSparrowhawk, K. / Kumar, R. / Harrison, J. et al. | 2014
-
Outpatient Treatment of Adolescents in Japan with Drugs for Attention Deficit DisordersInagaki, A. / Nishimura, Y. / Otsuka, H. / Hirakawa, H. / Hatou, K. / Kubota, Y. / Watanabe, Y. / Miki, K. / Endoh, Y. et al. | 2014
-
Analysis of ‘Revolving Door' Patients in Opioid Dependent Patients: the Impact of Treatment Discontinuation on Relapse Rates and Health Care Costs in us Public Health Insurance ClaimsClay, E. / Zah, V. / Kharitonova, E. / Ruby, J. / Aballéa, S. / Khemiri, A. et al. | 2014